-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VZV9NTNbchrzW68Ao/I2O5eovNlEYn2atgKHynG/evhY2QUTxWUYW8OO1ynT7QcC 92lQkEnuUFmTX3eKVZ2HZQ== 0001193125-08-238165.txt : 20081118 0001193125-08-238165.hdr.sgml : 20081118 20081118073109 ACCESSION NUMBER: 0001193125-08-238165 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 104 CONFORMED PERIOD OF REPORT: 20081118 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20081118 DATE AS OF CHANGE: 20081118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTH NET INC CENTRAL INDEX KEY: 0000916085 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 954288333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12718 FILM NUMBER: 081196988 BUSINESS ADDRESS: STREET 1: 21650 OXNARD ST CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 8186766000 MAIL ADDRESS: STREET 1: 225 N MAIN ST CITY: PUEBLO STATE: CO ZIP: 81003 FORMER COMPANY: FORMER CONFORMED NAME: FOUNDATION HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19970513 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH SYSTEMS INTERNATIONAL INC DATE OF NAME CHANGE: 19940207 FORMER COMPANY: FORMER CONFORMED NAME: HN MANAGEMENT HOLDINGS INC/DE/ DATE OF NAME CHANGE: 19931213 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported):

   November 18, 2008

 

 

Health Net, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

1-12718

 

95-4288333

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

21650 Oxnard Street, Woodland Hills, California

   

91367

(Address of principal executive offices)       (Zip Code)

 

Registrant’s telephone number, including area code:

  (818) 676-6000

 

 

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01. Regulation FD Disclosure.

On November 18, 2008, members of the management team of Health Net, Inc. (the “Company”) will be meeting with investors and analysts in connection with the Company’s annual investor conference. During this meeting, the Company intends to address its prospects and historical performance, provide additional detail regarding its earnings guidance for 2009, reaffirm its earnings guidance for the full year of 2008, and discuss the recent management reorganization, all as announced in a press release and conference call on November 4, 2008. A copy of the Company’s third quarter 2008 earnings press release was attached as Exhibit 99.1 to the Form 8-K furnished by the Company to the Securities and Exchange Commission (the “SEC”) on November 4, 2008. As previously announced, the Company will have a live audio webcast of its presentation at the meeting at 8:00 a.m. (Eastern Time) on November 18, 2008 from the “Investor Relations–Presentations and Webcasts” section of its website at www.healthnet.com. A replay of the Company’s presentation will be available on the Company’s website, and the Company’s slides for the presentation are attached to this Current Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

CAUTIONARY STATEMENT: Certain statements made in this report contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. All statements, other than statements of historical information provided herein, including but not limited to the guidance for future periods included herein and the assumptions underlying such projections, may be deemed to be forward-looking statements. These statements are based on management’s analysis, judgment, belief and expectation only as of the date hereof, and are subject to uncertainty and changes in circumstances. Without limiting the foregoing, the guidance as to expected future period results and statements including the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend” and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially due to, among other things, rising health care costs, negative prior period claims reserve developments, additional investment portfolio impairment charges, changes in the economy, volatility in the financial markets, trends in medical care ratios, unexpected utilization patterns or unexpectedly severe or widespread illnesses, membership declines, rate cuts affecting our Medicare or Medicaid business, issues relating to provider contracts, litigation costs, regulatory issues, operational issues, health care reform and general business and market conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included within the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the SEC and the risks discussed in the Company’s other periodic filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly revise its guidance, the assessment of the underlying assumptions or any of its forward-looking statements to reflect events or circumstances that arise after the date of this report.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1    Health Net, Inc. Presentation Slides for Annual Investor Conference, dated November 18, 2008.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Health Net, Inc.
  November 18, 2008     By:   /s/ Linda V. Tiano
       

Name: Linda V. Tiano

Title: Senior Vice President, General Counsel and Secretary

EX-99.1 2 dex991.htm HEALTH NET, INC. PRESENTATION SLIDES FOR ANNUAL INVESTOR CONFERENCE Health Net, Inc. Presentation Slides for Annual Investor Conference
Health Net, Inc.
Health Net, Inc.
Investor Conference
Investor Conference
November 18, 2008
Exhibit 99.1


2
Cautionary Statement
All statements in this presentation, other than statements of historical information
provided herein, including but not limited to the guidance for future periods included
herein and the assumptions underlying such projections, may be deemed to be forward-
looking statements and as such are subject to a number of risks and uncertainties. These
statements are based on management’s analysis, judgment, belief and expectation only
as of the date hereof, and are subject to uncertainty and changes in circumstances.
Without limiting the foregoing, the guidance as to expected future period results and
statements including the words “believes,”
“anticipates,”
“plans,”
“expects,”
“may,”
“should,”
“could,”
“estimate,”
“intend”
and other similar expressions are intended to
identify forward-looking statements. Actual results could differ materially due to, among
other things, rising health care costs, negative prior period claims reserve developments,
additional investment portfolio impairment charges, changes in the economy, volatility in
the financial markets, trends in medical care ratios, unexpected
utilization patterns or
unexpectedly severe or widespread illnesses, membership declines, rate cuts affecting our
Medicare or Medicaid business, issues relating to provider contracts, litigation costs,
regulatory issues, operational issues, health care reform and general business and market
conditions. Additional factors that could cause actual results to differ materially from
those reflected in the forward-looking statements include, but are not limited to, the risks
discussed in the “Risk Factors”
section, included within the company's most recent Annual
Report on Form
10-K and subsequent quarterly reports on Form 10-Q filed with the SEC.
Audience members are cautioned not to place undue reliance on these forward-looking
statements. The company undertakes no obligation to publicly revise its guidance, the
assessment of the underlying assumptions or any of its forward-looking statements to
reflect events or circumstances that arise after the date of these presentations.


3
Non-GAAP Measures
These presentations include quarterly and full-year income statement
measurements that are not calculated and presented in accordance
with
Generally Accepted Accounting Principles. Audience participants should
refer to the reconciliation table available in the company’s third quarter
2008 earnings press release, available on the company’s Web site at
www.healthnet.com, which reconciles certain non-GAAP financial
information to GAAP financial information.
These presentations also include underlying health care cost trend
metrics that reflect the impact of prior period incurred development
which has been included in the appropriate incurred period.
Management believes that the non-GAAP financial information discussed
in these presentations is useful as it provides the audience a basis to
better understand the company’s results by excluding items that are not
indicative of our core operating results for the periods presented. In
addition, the company believes that the underlying health care cost
metrics provide the audience with a more accurate assessment of these
trends which the company uses to appropriately price its products.


4
Registration & Continental Breakfast
7.30 a.m.
8.00 –
8.30 a.m.
Introduction & Strategic Review
Angie McCabe, Vice President, Investor Relations
Jay Gellert, President & Chief Executive Officer
8.30 –
10.00 a.m.
Review of Operations & Operations Strategy Update
Jim Woys, Chief Operating Officer
Federal Services / MHN
Steve Tough, President, Health Plans and Government Programs
Medicare Programs
Scott Kelly, Chief Government Programs Officer
California Market
Steve Sell, President, Health Net of California
10.00 –
10.30 a.m.
Financial Review
Joseph Capezza, Chief Financial Officer
10.30 –
11.00 a.m.
Q&A Panel
11.00 a.m.
Closing Remarks
Jay Gellert, President & Chief Executive Officer
Agenda


Health Net, Inc.
Health Net, Inc.
Investor Conference
Investor Conference


Strategic Review
Strategic Review
Jay Gellert
President and Chief Executive Officer
November 18, 2008


7
Strategic Review
Strategic Review
Basic assets are solid
TRICARE/MHN
California/Oregon
2008 performance was impaired by:
Medicare
Arizona
Northeast
The 2009 bid addresses the Medicare issues
While our other operations have critical mass,
there is a scale problem in:
Arizona
Northeast
The balance sheet is strong


8
HNT Business Unit Profile
HNT Business Unit Profile
High
High
Revenue represented by size of circle
Pretax Margin
CA/OR
SPD
HNFS/MHN
NE
AZ


9
Northeast and Arizona:
Northeast and Arizona:
Scale Issues
Scale Issues
2009 combined revenues expected to be between $3.7 billion to
$3.8 billion
Combined year-end 2008 membership of:
580,000 Commercial members
131,000 Medicare members
46,000 Medicaid members
Operate G&A at approximately 12 percent of premium.          
With scale, the marginal G&A of these businesses should be
approximately 7 percent of premium
Health care unit costs are higher than the median for the
competition by an average of at least 5 percent
Projected to operate on a breakeven basis in 2009 due to
Medicare improvements
Approximately $500 million of excess cash in these entities to
meet regulatory requirements


10
TRICARE/MHN, California/Northwest
TRICARE/MHN, California/Northwest
and Senior Products
and Senior Products
Combined revenues expected to be approximately
$12 billion in 2009
These operations have approximately:
1.5 million commercial members
165,000 MA members
760,000 Medicaid members
500,000 PD members
2.9 million TRICARE eligibles
5 million EAP members
Health
plan
G&A
is
expected
to
be
approximately
8.7%
in
2009
Health plan and HNFS health care costs are competitive
Expected to generate approximately $400 million of pretax
income in 2009


11
Our Direction
Our Direction
Address Arizona/Northeast issues
Achieve 2009 plan
Maintain and improve balance sheet
Continue to review strategy


Introduction to the
Introduction to the
Operations Organization
Operations Organization
Jim Woys
Executive Vice President
and Chief Operating Officer
November 18, 2008


13
Reorganized, energized and ready-to-go
Most successful managers in the company
Know markets and customers
Focused on California, Oregon
and Federal Services
Release
potential
of
HNT’s
opportunities
for
near-
and
long-term improvement
A New Management Team


14
Immediate Focus
Grow Profitably
Actively manage the trend
Improve
operational performance


15
Profitable Growth
Profitable Growth
Unified sales, market,
product approach
Appropriate pricing structure
Clear, targeted growth in
identified markets and segments
Margin expansion and
profitable growth
Key Strategy
Key Strategy
Attack and defend where clear value proposition exists
Key Commercial Markets
Key Commercial Markets
California, Oregon
Key Lines of Business
Key Lines of Business
Commercial, Medicare, Medicaid, TRICARE, MHN
Expected Results
Expected Results
Actions Taken
Actions Taken


16
Managing Trend
Managing Trend
Results-oriented structure
Geographical review of hospital
and provider contracts
Care management programs
Predictable health care costs
Key Strategy
Key Strategy
Predictability and proactive management
Key Management Tactics
Key Management Tactics
Unit cost –
multi-year agreements,
administrative ease, billed charges
Utilization –
predictive modeling, high intensity care
management, appropriate hospitalization, analytics
and reporting
Expected Results
Expected Results
Actions Taken
Actions Taken


17
Operational Excellence
Operational Excellence
Consolidated operation
management, analytics
and reporting
Reduced variation
Outsourcing transactional jobs
Driving electronic channel making
it easy to do business with HNT
Better Service –
less cost
Key Strategy
Key Strategy
Great at the basics
Key Management Tactics
Key Management Tactics
Consolidate and centralize
Predictable, stable core operations
Performance driven
Expected Results
Expected Results
Actions Taken
Actions Taken


18
Near-Term Goals
Improve shareholder value
Increase value of franchise
Deliver profitable results


19
The Operations Team
Steven Tough
President, Health Plans and Government Programs
Steven Sell
President, Health Net of California
Scott Kelly
Chief Government Programs Officer
John Sivori
President, Regional Health Plans and Pharmacy
Dr. Jonathan Scheff
Chief Medical Officer
Scott Law
Chief Network Management Officer
Kathleen Richard
Customer Experience Officer
Duncan Rose
Chief Information Officer


2008 -
2008 -
2009
2009
Operational Performance
Operational Performance
Jim Woys
Executive Vice President
and Chief Operating Officer
November 18, 2008


21
2008 and 2009 Guidance
2008 and 2009 Guidance
2008
2009
Membership
Commercial Risk
-8 to -9%
-3 to -5%
Medicaid
+6 to 7%
+2 to +3%
Medicare Advantage (incl
PFFS)
+20 to 25%
-1 to -2%
PDP
+40 to 45%
-15 to -20%
Commercial Yields
~ 8.3%
~ 9 to 9.5%
Commercial HCC Trends
~ 10.9%
~ 40 to 60 bps < yield
G&A Expense Ratio
~ 9.5%
~ 9.6 to 9.8%


22
Understanding the Underlying Trend
Understanding the Underlying Trend
Conducted in-depth analyses of:
Conducted in-depth analyses of:
Underlying trends for all markets and all segments
for 2007, 2008 and expected 2009
Actual trends based on incurred dates after
adjusting for all prior period changes
Prior pricing actions and product and benefit designs
Current pricing actions for 2009
Current network contract status and effect of recent
and current contract negotiations on 2009 unit costs
Utilization management practices including current
and prospective initiatives


23
Guidance vs. Underlying Trend
Guidance vs. Underlying Trend
2008
2009
Guidance
10.9%
8.6% -
8.9%
Effect Guardian
(2.7%)
Revised
8.2%
Effect of Prior Period
(1.4%)
.5%
Net Underlying Trend
6.8%
9.1% -
9.4%


24
2008 and 2009 Commercial
2008 and 2009 Commercial
Health Care Cost Trends
Health Care Cost Trends
Underlying health care cost trend after adjusting for prior period development and effect of Guardian transaction
(1)
(1)
Commercial
'07 -
'08
'08 -
'09
Yield
8.3%
9.0% -
9.5%
Health Care Cost
Physician
Physician -
Claims
2.4%
4.4%
Physician -
Capitation
5.5%
7.4%
Physician Total
4.0%
6.2%
Hospital
Hospital -
Inpatient
10.1%
9.5%
Hospital -
Outpatient
8.5%
10.5%
Hospital -
Capitation
3.9%
12.0%
Hospital Total
9.0%
11.1%
Pharmacy
6.3%
4.2%
Other
7.3%
15.0%
Total
6.8%
9.1%
% Change


25
2008 Commercial Unit Cost
2008 Commercial Unit Cost
and Utilization Metrics
and Utilization Metrics
Underlying operational health care cost metrics after adjusting for prior period development
(1)
(1)
Unit Cost & Utilization
Q1
Q2
Q3
Hospital
Inpatient
Days/1,000
5.0%
4.1%
10.7%
Admits/1,000
1.3%
2.2%
6.6%
ALOS
3.6%
1.8%
3.8%
Cost/Day
-6.3%
-5.5%
8.3%
Outpatient Surgery
Cases/1,000
-0.4%
2.7%
5.9%
Cost/Case
7.1%
10.6%
7.2%
ER
Cases/1,000
0.1%
-1.8%
1.3%
Cost/Case
9.6%
13.9%
10.5%
% Change (year-over-year)
2008


26
Underlying Medicare Trend
Underlying Medicare Trend
2008
2009
Expected
6.4%
4.5%
Effect of Prior Period
.2%
(.1)%
Net Underlying Trend
6.6%
4.4%
Note: Metrics exclude Medicare Part D


27
2007 to 2009 Medicare
2007 to 2009 Medicare
Health Care Costs
Health Care Costs
Underlying health care cost trend after adjusting for prior period development and effect of Guardian transaction
(1)
(1)
Medicare Advanatage
'07 -
'08
'08 -
'09
Yield
2.6%
6.0%
Health
Care
Cost
Physician
Physician -
Claims
13.6%
14.1%
Physician -
Capitation
-2.1%
-6.1%
Physician Total
5.0%
3.7%
Hospital
Hospital -
Inpatient
15.4%
6.8%
Hospital -
Outpatient
3.6%
11.2%
Hospital -
Capitation
-15.7%
-12.2%
Hospital Total
6.4%
4.6%
Pharmacy
10.0%
5.3%
Other
35.3%
8.7%
Total
6.6%
4.4%
% Change


28
2008 Medicare Unit Cost
2008 Medicare Unit Cost
and Utilization
and Utilization
Underlying operational health care cost metrics after adjusting for prior period development; excludes Private Fee-for-Service
(1)
(1)
Medicare Advantage
Unit Cost & Utilization
Q1
Q2
Q3
Hospital
Inpatient
Days/1,000
5.0%
4.1%
10.7%
Admits/1,000
1.3%
2.2%
6.6%
ALOS
3.6%
1.8%
3.8%
Cost/Day
-6.3%
-5.5%
-4.3%
SNF
Days/1,000
-0.4%
1.0%
5.7%
Admits/1,000
0.8%
2.6%
-0.7%
ALOS
-1.2%
-1.5%
0.5%
Cost/Day
-9.1%
-0.4%
-5.2%
Outpatient Surgery
Cases/1,000
4.4%
4.1%
2.6%
Cost/Case
-4.9%
-3.5%
-2.5%
ER
Cases/1,000
3.8%
7.2%
5.5%
Cost/Case
-12.9%
-7.4%
-5.4%
2008


Commercial
Commercial


30
2009 Underlying Health Care Cost Trend:
2009 Underlying Health Care Cost Trend:
HNCA –
HNCA –
Commercial
Commercial
Hospital trends reflect conversion of two hospitals from capitated to noncapitated arrangements
Underlying health care cost trend after adjusting for prior period development
(1)
(2)
(1)
(2)
'07 -
'08
'08 -
'09
Yield
6.5%
9.1%
Health Care Cost
Physician
Physician -
Claims
6.1%
5.3%
Physician -
Capitation
5.0%
7.2%
Physician Total
5.3%
6.8%
Hospital
Hospital -
Inpatient
12.9%
10.3%
Hospital -
Outpatient
9.9%
12.4%
Hospital -
Capitation
1.8%
9.8%
Hospital Total
10.5%
11.0%
Pharmacy
6.5%
3.4%
Other
-11.7%
11.2%
Total
7.8%
8.8%
% Change


31
2008 Financial Performance:
2008 Financial Performance:
HNCA –
HNCA –
Commercial
Commercial
Based on membership in noncapitated hospital arrangements (approximately 82% of total membership)
Underlying operational health care cost metrics after adjusting for prior period development
(1)
(2)
(1)
(2)
Unit Cost & Utilization
Q1
Q2
Q3
Hospital
Inpatient
Days/1,000
7.2%
1.0%
3.1%
Admits/1,000
-0.1%
-2.4%
0.6%
ALOS
7.3%
3.5%
2.5%
Cost/Day
6.2%
3.1%
5.5%
Outpatient Surgery
Cases/1,000
1.1%
4.0%
5.0%
Cost/Case
4.3%
9.4%
5.1%
ER
Cases/1,000
-1.2%
-1.5%
1.1%
Cost/Case
7.7%
11.7%
5.3%
% Change (year-over-year)
2008


32
2008 Performance:
2008 Performance:
HNCA –
HNCA –
Commercial
Commercial
Pressure on premium yields due to
competitive environment
Higher health care costs
Flu season
Late development impacting unit
cost assumptions
Two groups converted from dual to
shared risk
Cancelled hospital contracts
Savings from cost containment activities
less than expected


33
2009 Expectations:
2009 Expectations:
HNCA –
HNCA –
Commercial
Commercial
Focused, clear and simple plan
block-and-tackle
82% book is priced at a yield of 9.1%
99% of Special Accounts (1/3 membership) under contract
Assumes 1% higher rating compared to 2008 and a lower
impact from mix changes (geography, network, and account)
Baseline data for pricing is known
Professional:   74%
Institutional:   57%
Other:            62%
Conservative expectations on utilization improvement
Percent under contract


34
2009 Health Care Cost Trend Expectations:
2009 Health Care Cost Trend Expectations:
Oregon -
Oregon -
Commercial
Commercial
Underlying health care cost trend after adjusting for prior period development
(1)
(1)
'07 -
'08
'08 -
'09
Yield
5.7%
7.9%
Health Care Cost
Physician
Physician -
Claims
7.3%
6.6%
Physician -
Capitation
0.0%
0.0%
Physician Total
7.3%
6.6%
Hospital
Hospital -
Inpatient
14.3%
4.5%
Hospital -
Outpatient
3.8%
2.9%
Hospital -
Capitation
0.0%
0.0%
Hospital Total
8.9%
3.7%
Pharmacy
11.6%
4.9%
Other
9.4%
8.9%
Total
8.7%
5.1%
% Change


35
2009 Health Care Cost Trend Expectations:
2009 Health Care Cost Trend Expectations:
Northeast -
Northeast -
Commercial
Commercial
Underlying health care cost trend after adjusting for prior period development and effect of Guardian transaction
(1)
(1)
'07 -
'08
'08 -
'09
Yield
6.7%
5.3%
Health Care Cost
Physician
Physician -
Claims
2.3%
4.0%
Physician -
Capitation
3.2%
9.0%
Physician Total
2.5%
4.8%
Hospital
Hospital -
Inpatient
0.0%
6.3%
Hospital -
Outpatient
6.4%
6.8%
Hospital -
Capitation
56.7%
155.1%
Hospital Total
3.3%
7.5%
Pharmacy
7.6%
5.2%
Other
52.5%
19.6%
Total
5.0%
6.5%
% Change


36
2009 Health Care Cost Trend Expectations:
2009 Health Care Cost Trend Expectations:
Arizona -
Arizona -
Commercial
Commercial
Underlying health care cost trend after adjusting for prior period development
(1)
(1)
'07 -
'08
'08 -
'09
Yield
4.7%
8.0%
Health Care Cost
Physician
Physician -
Claims
9.7%
4.3%
Physician -
Capitation
11.4%
11.1%
Physician Total
9.7%
4.5%
Hospital
Hospital -
Inpatient
6.8%
14.9%
Hospital -
Outpatient
13.2%
9.6%
Hospital
-
Capitation
9.8%
4.9%
Hospital Total
9.3%
12.6%
Pharmacy
12.0%
9.8%
Other
13.3%
26.9%
Total
9.9%
9.4%
% Change


37
2008 Performance:
2008 Performance:
Oregon, Northeast, Arizona –
Oregon, Northeast, Arizona –
Commercial
Commercial
Oregon
Continued solid performance
Membership = generally flat
Emerging strength in small group market (4Q08)
Revenue
Lower than necessary yield in mid-size and large groups
Health care costs
Higher than normal frequency of high cost cases
Northeast
Pricing discipline resulted in commercial membership losses
Lapsed less profitable large group business
Maintained competitive MCR’s
G&A level impacted pricing competitiveness
Arizona
Higher than expected commercial catastrophic claims and case-mix negatively
impacting 2008 run-rate
Overall care intensity driving higher than expected unit cost trends across all products
and segments
Increased physician trends driven solely by higher utilization and coding intensity
across all products and segments
Solid
Medicare
Advantage
growth,
but
lower
than
expected
margins
due
to
the
higher
than expected health care cost trends


38
2009 Expectations:
2009 Expectations:
Oregon, Northeast, Arizona
Oregon, Northeast, Arizona
Oregon
Continued positive performance
Expect some health care cost recovery by assuming normal frequency of
high cost cases
Positive yield on mid-size and large group business due to the pricing
corrections occurring in the market
Northeast
Stabilizing commercial membership losses
Implementing targeted pricing actions to improve risk selection and
stimulate middle market growth
Addressing expense levels to improve competitiveness
NJ small group margin deterioration due to minimum loss ratio regulatory
requirement of 80%
Arizona
Commercial book will be repositioned by 12/31/09
Pricing discipline will slow growth but improve performance
Provider unit cost trends expected to be single digit and the network is
expected to continue to grow
Continued medical management discipline seeking upside cost mitigation
opportunities with a focus on improving patient care


Medicare
Medicare


40
2009 Underlying Health Care Cost Trends:
2009 Underlying Health Care Cost Trends:
Medicare
Medicare
Underlying health care cost trend after adjusting for prior period development
(1)
(1)
Medicare Advantage
'07 -
'08
'08 -
'09
Yield
2.7%
6.2%
Health Care Cost
Physician
Physician -
Claims
13.6%
14.1%
Physician -
Capitation
-2.1%
-6.1%
Physician Total
5.0%
3.7%
Hospital
Hospital -
Inpatient
15.4%
6.8%
Hospital -
Outpatient
3.6%
11.2%
Hospital -
Capitation
-15.7%
-12.2%
Hospital Total
6.4%
4.6%
Pharmacy
10.0%
5.3%
Other
35.3%
8.7%
Total
6.6%
4.4%
% Change


41
Medicare: What Happened in 2008?
Medicare: What Happened in 2008?
Benefit leader in 2008
Experienced substantial growth across MAPD
Early 2008 experience led to margin deterioration
Rich benefits and low member out-of-pocket costs
Higher utilization than planned
Lower RAF scores than industry
Revenue
HCC
GM
Member Months
MCR (bps)
Total MA
29.5%
34.4%
-3.9%
26.1%
-331
PMPM change
2.6%
6.6%
-23.8%
2007-2008


42
Priced 2009 bids to address MCR concerns across
all products
Factored for higher-than-expected HCC in 2008
Adjusted premiums and benefit design (specialist
co-pay, hospital co-pay) to improve gross margin –
will result in membership deterioration in some plans
Contracted industry leading risk adjustment services
Targeted Medicare medical management practices
Revenue
HCC
GM
Member Months
MCR (bps)
Total MA
7.4%
5.6%
24.8%
1.1%
154
PMPM change
6.0%
4.4%
23.5%
2009 Expectations: Medicare
2009 Expectations: Medicare
2008-2009


Federal Services / MHN
Federal Services / MHN
Steve Tough
President, Health Plans and
Government Programs
November 18, 2008


44
2009 and Beyond
2009 and Beyond
Relationships with our customers are very strong
Service and financial performance has been excellent
TRICARE, Military & Family Life Consultants (MFLC)
and EAP programs remain solid cornerstones
Base of operations provides a sound foundation for  
the future
2009 and beyond plan is geared for growth through
diversification
Consolidated MHN and HNFS leadership into a
combined management structure
Focused on using a common infrastructure and gaining
efficiencies across both organizations


45
Current TRICARE Contract
Current TRICARE Contract
Excellent performance—meeting or exceeding all contract
requirements and benchmarks
Top-to-bottom relationship with customer is solid
Financial results
Expect to reach $2.6 billion in total contract revenue in
2008 (8.5% increase over 2007)
Expect to achieve 95% government contract ratio for
the full year 2008
On track to achieve the health care cost target for
Option Period 5


46
Current TRICARE Contract
Current TRICARE Contract
Confident of ability to deliver on 2009 plan
On track to meet Option Period 5 performance targets
Current TRICARE business model continues through
April 2010
Engaged in Option Period 6 discussions
Based on previous experience, we expect an increase in
revenue consistent with the increase in health care costs
Expect Government Contract Ratio to be in the
95.0% to 95.5% range


47
TRICARE Contract
TRICARE Contract
Re-Procurement Overview
Re-Procurement Overview
Proposal delivered at end of June 2008
Terms are valid for 270 days (through March 27, 2009)
Statement of work is nearly the same as current
TRICARE contract
Period of Performance, as currently stated in the RFP
Transition from June 1, 2009 to March 31, 2010
First Option Period (of five) from April 1, 2010 to
March 31, 2011
Well-positioned for award
Low-risk, best value solution
Strong past performance
High stakeholder satisfaction


48
TRICARE Contract
TRICARE Contract
Re-Procurement Overview
Re-Procurement Overview
Three factors in evaluating the proposals
Technical approach
Past performance
Price/cost
Extension of current contract
Re-procurement terms extended the period of
performance for the current contract through
March 31, 2010 
Government has the authority to extend for two
additional 6-month periods
What will happen?


49
Customer remains our number one priority
TRICARE program continues to run extremely well
Ongoing partnership with the Government on innovative solutions
for military beneficiaries
Continued high satisfaction with the TRICARE benefit and
Health Net as a contractor
Recently achieved the highest satisfaction levels among all
stakeholders since the beginning of the contract and the
highest overall satisfaction level to-date in the award fee
process
98% satisfaction among military treatment
facility commanders
Exceptional beneficiary satisfaction (using multiple
measures) –
more than a 90% satisfaction rate
Not a single contractual deficiency during the entire term
of the contract
Metric performance and satisfaction are the primary basis on
which past performance is evaluated
Solid TRICARE Performance
Solid TRICARE Performance


50
MFLC: A Department of Defense Program
MFLC: A Department of Defense Program
Short-term, situational non-medical counseling services
and outreach
Assists service members and their families through the
challenges of military life
5-year, $300 million contract awarded to MHN effective
April 1, 2007
Started as an MHN pilot program in 2004
Task order driven
More than 500 consultants at 186 locations worldwide seeing
over 300,000 people per month
Substantial year-over-year revenue growth:
$50 million in 2007, on target for $100 million in 2008 and 
budgeting $140 million in 2009
Confident in achieving 2009 revenue:
Demand for base non-medical counseling services is increasing
Personal financial counseling added to scope of contract


51
Opportunities
Opportunities
International
Dubai Health Authority
Evolving opportunities in the Middle East
Department of Defense
TRICARE Overseas
MFLC expansion
TRICARE/Medicare Pilot
National Guard and Reserve health care service support
Single team focused on opportunities and
leveraging the infrastructure:


52
Opportunities
Opportunities
Department of Veterans Affairs
Regional programs –
civilian network and
clinic support
Mental/behavioral health surge capacity
VetAdvisor
expansion (includes TBI and
PTSD screening)
Other government and commercial entities
Targeted commercial market segments (public
employers, labor & trust, student health)
Targeted Medicare and Medicaid opportunities
“CalPERS-like”
scenarios
Growing need to support veterans and wounded, ill
and injured service members with TBI and PTSD


Health Net, Inc.
Health Net, Inc.
Investor Conference
Investor Conference


Medicare Programs
Medicare Programs
Scott Kelly
Chief Government Programs Officer
November 18, 2008


55
Medicare Advantage Market
Medicare Advantage Market
Broad array of products: HMO/HMO-POS, SNP, PFFS,
PPO, RPPO, PDP
Highly regulated and very competitive across
product lines
Market continues to grow
HNT accounted for greater than 35% of
industry growth in its markets
Regulatory challenges
Marketing limitations
Commission regulations
Competitive pricing in the market


56
Medicare Market View
Medicare Market View
Oregon
CCPs/PFFS/PDP
California
CCPs/PDP
PFFS/MedSup
Washington
PDP/PFFS
Arizona
CCPs/PDP
New Mexico
PDP/PFFS
Texas
PDP/PFFS
Connecticut
CCPs/PDP
PFFS
New York
PDP/PFFS
Hawaii
PDP/PFFS
CCPs & PDP
(may incl. PFFS)
PFFS & PDP
Note: PDP is offered in all 50 states
Massachusetts
PDP/PFFS
Virginia
PDP/ PFFS
North Carolina
PDP/ PFFS
Georgia
PDP/ PFFS
CCPs = Coordinated Care Plans
PFFS = Private Fee-for-Service
PDP = Prescription Drug Plan


57
Medicare Advantage Positioning
Medicare Advantage Positioning
Health Net is now the seventh largest MA plan nationally
Limited core market footprint
HNT led growth in its core markets
Limited PFFS engagement nationally
Health Net grew by 25% nationally
Predominance of growth in network-based products (HMO/PPO)
Rank
Plan
Dec '07
Oct '08
% Share
Growth
% Growth
1
UnitedHealth Group, Inc.
1,430,280
1,524,600
15.6%
94,320
6.6%
2
Humana Inc.
1,188,862
1,371,646
14.0%
182,784
15.4%
3
Kaiser Foundation Health Plan, Inc.
823,189
837,367
8.6%
14,178
1.7%
4
WellPoint, Inc.
369,638
461,882
4.7%
92,244
25.0%
5
Coventry Health Care Inc.
282,824
376,827
3.8%
94,003
33.2%
6
Aetna Inc.
190,431
362,317
3.7%
171,886
90.3%
7
Health Net, Inc.
232,284
290,033
3.0%
57,749
24.9%
8
Blue Cross Blue Shield of Michigan
190,659
278,932
2.8%
88,273
46.3%
9
Highmark Inc.
233,477
266,390
2.7%
32,913
14.1%
10
Universal American Corporation
232,696
242,777
2.5%
10,081
4.3%
Top 10 Total
5,174,340
6,012,771
61.4%
838,431
16.2%
Total Market
8,468,465
9,791,401
100.0%
1,322,936
15.6%
Source: CMS Enrollment data


58
Medicare Part D Positioning
Medicare Part D Positioning
Health Net ranks eighth nationally among PDP plans
Health Net grew by 45% in 2008
Adjusted bids to address MCR concerns, resulting in 2009 projected
membership deterioration of approximately 98,000 members
Expected 2009 MCR improvement: 290 to 300 basis points
Expected 2009 gross margin improvement: $5 million to $7 million
Rank
Plan
Dec '07
Oct '08
%Share
Growth
%Growth
1
UnitedHealth Group, Inc.
4,891,231
4,095,869
23.5%
-795,362
-16.3%
2
Humana Inc.
3,458,903
3,094,310
17.7%
-364,593
-10.5%
3
Universal American Corporation
1,643,593
1,835,402
10.5%
191,809
11.7%
4
WellPoint, Inc.
1,229,432
1,394,592
8.0%
165,160
13.4%
5
WellCare Health Plans, Inc.
982,559
989,145
5.7%
6,586
0.7%
6
Coventry Health Care Inc.
722,046
912,261
5.2%
190,215
26.3%
7
CVS Caremark Corporation
361,484
561,486
3.2%
200,002
55.3%
8
Health Net, Inc.
368,121
534,671
3.1%
166,550
45.2%
9
Longs Drug Stores Corporation
249,433
464,188
2.7%
214,755
86.1%
10
Medco Health Solutions, Inc.
314,833
423,718
2.4%
108,885
34.6%
Top 10 Total
14,221,635
14,305,642
82.0%
84,007
0.6%
Market Total
17,239,108
17,438,708
100.0%
199,600
1.2%
Source: CMS Enrollment data


59
2008 Performance
2008 Performance
Benefit leader in 2008
Experienced substantial growth across MAPD
Early 2008 experience led to margin deterioration
Rich benefits and low member out-of-pocket costs
Higher utilization than planned
Lower RAF scores than industry
2007 - 2008 (Percent Change)
Revenue
HCC
GM
Member
MCR
(pmpm)
(pmpm)
(pmpm)
Months
(bps)
Total MA
>2%
>6%
~(24%)
~26%
~(330)


60
2009 Membership Projections
2009 Membership Projections
(in thousands)
2008
Expectations
2009
Guidance
% Change
California
132
             
121
       
Oregon
23
               
26
         
Arizona
67
               
61
         
Northeast
58
               
62
         
Expansion States
16
               
21
         
Total Medicare Advantage
295
            
290
      
-1 to -2 %
Health Net
Medicare Advantage Enrollment


61
2009 Expectations
2009 Expectations
Priced 2009 bids to address MCR concerns across
all products
Factored for higher than expected HCC in 2008
Adjusted premiums and benefit design (specialist
co-pay, hospital co-pay) to improve gross margin –
will cause membership deterioration in some plans
Contracted industry-leading risk adjustment services
Targeted Medicare medical management practices
2008 - 2009 (Percent Change)
Revenue
HCC
GM
Member
MCR
(pmpm)
(pmpm)
(pmpm)
Months
(bps)
Total MA
>6%
>4%
>23%
~1%
>150


62
Opportunities
Opportunities
Revenue enhancement through RAF score improvement
Continuation of industry-proven RAF initiatives
in all markets
Supplement RAF activity with network
management support
Data collection efforts expanded to pull directly from
source systems
Ensures complete retrieval of all diagnosis codes
impacting 2008 and 2009 revenue
Expansion of chart audits to include 100% of members
every other year
Execute on member retention strategy
Market differentiators such as Healthy Heart program


California Market
California Market
Steve Sell
President
Health Net of California
November 18, 2008


64
California Market Dynamics
California Market Dynamics
Largest state in U.S. with 37 million people
Membership concentrated around high
population density areas
Highest managed care penetration in the U.S.
Slowing economy
>50,000 Members
20,000-49,999 Members
10,000-19,999 Members
5,000-9,999 Members
1,000-4,999 Members
500-999 Members
<499 Members
Health Net Membership
As of September 30, 2008


65
Market Positioning
Market Positioning
Why Buy A Health Net Product?
$7 billion health plan with
2.2 million members
Dominant network HMO
Strong network and provider
partnerships
Targeted geographies
Diversified product portfolio
Source: Health Leaders, January 2008 (includes ASO)


66
Action Plan
Action Plan
Focus on the basics
Sales and account management
Product and marketing
Underwriting discipline; population and account level
Build on strengths and key differentiators
Competitive HMO offering
HMO Portfolio (EOA, Silver, Salud, Optimizer)
Responsive and high touch service
Strong provider network and medical management
Play to our “sweet spot”
Targeted geographies
Segments within the segments


67
Focus on Sub-Segments
Focus on Sub-Segments
Segments/
Sub-Segments
2008
Revenue
Membership
(12/08
Projected)
Membership
(12/09
Forecast)
B/(W)
Total Commercial
$5.0   B
1,355 K
(54,000)
Large
–SPA
–L&T
–Mid
$3.5   B
1.7   B
0.3   B
1.5   B
908 K
448 K
74 K
386 K
(36,000)
(27,000)
0               
(9,000)
Small/Individual
–Small
–Individual
$1.4   B
1.1   B
0.3   B
413 K
313 K
100 K
(16,000)
0
(16,000)


68
Action Plan
Action Plan
Market Segment
Health Net –
Sweet Spot
SPA/L&T
Focus:
Large CA-centric employers and unions
Need:
High-touch account management and service
Price-competitive HMO as slice offering
Low-cost offering without cost-shift
Mid-Market
Focus:
Public Entities (Municipalities, Schools, etc.)
Need:
Local touch with flexibility
Predictable rate increases
Small Groups
Focus:
Targeted Geographies and Brokers
Need:
–Solid standard product portfolio = “The wheel”
–Strong broker services
–Stable and predictable
Individual
Under strategic review


69
Challenges
Challenges
Convert difficult economic environment into an
opportunity by providing low-cost, profitable options to
individuals and groups
Focus on value proposition to offset pricing pressure
Improve
PPO product –
cost structure and servicing for
2010 and beyond
Price according to cost trends


70
Opportunities
Opportunities
Well-positioned in California for 2009
Strong HMO presence (11% market share)
Over 30 years of history in California
Provides a low cost option in a strained economy
Provide differentiated value compared to competition
One of two dominant local HMO options
(excluding Kaiser)
Local presence enables strong account management
Strong managed care capabilities through network
partnerships and “whole-person health”


71
Opportunities
Opportunities
Focus for 2009
Targeted growth in high value geographical markets
Offer low-cost options (without unaffordable cost shift)
Pursue local opportunities in small, mid-
and large
group markets
Demonstrated value proposition and strengthened
account services


Health Net, Inc.
Health Net, Inc.
Investor Conference
Investor Conference


Operations Strategy
Operations Strategy
Update
Update
Jim Woys
Executive Vice President
and Chief Operating Officer
November 18, 2008


74
Overview
Overview
Significant progress was made in 2008 in the following
activities as part of our operations strategy:
Performance Improvements
Performance Improvements
System Consolidation
System Consolidation
Application, Infrastructure,
Business Process Outsourcing
Application, Infrastructure,
Business Process Outsourcing


75
Achieving Operational Excellence
Achieving Operational Excellence
2007 to 2008
Recognize Opportunity
2008 to 2009
Year of Investment
2009 to 2011
Harvesting Benefits
Multiple systems
Manual processes
and workarounds
System
consolidation
planning
Sequencing of highest
benefit projects
Aging and inefficient
systems and technology
Application and
infrastructure
outsourcing
Best-in-class
outsourcing partners to
extend capabilities
High cost locations
and functions
Consolidation of
processes,
management,
footprint
Reduced headcount
Business process
outsourcing
Strategic sourcing
Multiple data warehouses
Inconsistent operational
metrics
Redundant analytical
functions
Consolidating
operations
Consistent metrics
and analytics
Performance-focused
operations


76
Improve service delivery while reducing costs
Economically replace aging technology
Outsource commoditized IT services
Improve quality and reliability of IT
development work products
Eliminate redundancies and variation and
increase performance
Improve customer service capabilities
Launch new electronic tools
Consolidate performance metrics
Capability Improvements
Capability Improvements


77
Sustainable Results
Sustainable Results
2008
2009
2010
2011
(in thousands except for percentages)
Guidance
Guidance
Expected
Expected
Total Member Months  (excl. PDP)
38,231
         
36,889
         
37,488
         
38,314
         
Total G&A*
1,088,614
1,113,718
1,127,526
1,118,698
G&A % change (year-over-year)
-1.1%
2.3%
1.2%
-0.8%
Effect of Operations Strategy and G&A Management
Change from  3.5% inflation
expectations and adjusted for
membership changes
(54,733)
       
(29,488)
       
(36,064)
       
(42,484)
       
Cumulative impact
(54,733)
       
(84,221)
       
(120,285)
    
(162,769)
    
Adjusted G&A Expense Ratio
9.2%
9.1%
8.4%
7.7%
*Excludes MIP, stock-based compensation, Medicare Part D-related G&A expense, and regulatory and operations strategy-related charges


78
Cost Structure Repositioning
Cost Structure Repositioning
Operations Strategy Improvements
(In Millions)
Outsourcing accounts for approximately 50% of the overall improvement
Performance improvements are result of centralized and consolidated
operations, uniform metrics, use of electronic channel and decreased
use of outside services; leads to increased service levels


79
Restructuring Charge/Savings
Restructuring Charge/Savings
Operations Strategy Impact
(In Millions)
Restructuring charges include severance, retention, relocation, performance bonus,
consulting, and data center relocation
Break Even Year


80
Guidance vs. Actuals
Guidance vs. Actuals
Actual / Expectation
Guidance
2007
2008
2009
11.0%
10.2%
10.0%
9.5%
9.6%
G&A Exceeds Guidance
G&A Exceeds Guidance


Financial Review
Financial Review
Joseph C. Capezza
Executive Vice President
and Chief Financial Officer
November 18, 2008


82
Agenda
Agenda
2008 Results and Guidance
2009 Expectations


83
2008 Performance
2008 Performance
Commercial premium yields above original guidance
Lower commercial membership
Medicaid, Medicare Advantage and PDP membership grew
significantly during the year
Due to higher cost trends, primarily hospital unit cost and
utilization, year-over-year deterioration in MCR across all
lines of business
Strong G&A expense management
Negative cash flow due to legal and operations strategy charges
Strong, conservative balance sheet and investment portfolio


84
2008 Balance Sheet Metrics
2008 Balance Sheet Metrics
As of September 30, 2008
Cash and investment holdings
$2.2 Billion
Strong Liquidity Ratios:
Cash ratio
0.98
Current ratio
1.56
Debt-to-capital ratio
27.6%


85
Investment Portfolio Highlights
Investment Portfolio Highlights
Market Value
$1.8 Billion
Net unrealized losses
$43 Million
Market value yield-to-maturity
5.3%
Average coupon
5.1%
Average duration
3.9 years
Average rating
AA+
Subprime risk
-0-
As of September 30, 2008


86
Agenda
Agenda
2008 Results and Guidance
2009 Expectations


87
2009 Earnings Guidance
2009 Earnings Guidance
Year-end Membership
Commercial Risk  -3 to -5%
Medicaid  +2 to +3%
Medicare Advantage  -1 to -2%
PDP  -15 to –20%
Consolidated Revenues
$15.5 to $16 billion
Commercial Premium Yields
~ 9 to 9.5%
Commercial Health Care Cost Trends
~ 40 to 60 bps < yield
Selling Cost Ratio
~ 2.9%
Gov’t Contract Ratio
~ 95.0 to 95.5%
G&A Expense Ratio
~ 9.6 to 9.8%
Tax Rate
~ 38.5 to 38.7%
Shares Outstanding
104 –
105 million
EPS*
$2.25 to $2.40
* 2009 guidance excludes expected operations strategy-related charges of $70 million to $80 million


88
Key Drivers of 2009 EPS Improvement
Key Drivers of 2009 EPS Improvement
* *2009 guidance excludes expected operations strategy-related charges of $70 million to $80 million
* Excludes nine months YTD 2008 litigation-related charges of $59 million, operations strategy-related charges of $53 million, investment
impairment of $15 million and expected 4Q08 operations strategy-related charges of $30 million to $35 million
EPS
EPS
Guidance
Midpoint
2008 Guidance*
$1.85-$1.89
1.87
$     
Medicare MCR/membership
0.55
$     
Commercial MCR/membership
0.25
$     
Gov't & Specialty Services
0.07
$     
Lower Weighted Average Share Count
0.03
$     
SG&A/D&A
(0.25)
$    
Medicaid Rate Reductions
(0.11)
$    
Investment Income
(0.09)
$    
Other P&L Items
0.00
$     
2009 Guidance**
$2.25-$2.40
2.32
$     


89
Cash Position at the Parent Company
Cash Position at the Parent Company
($ Millions)
Actual cash at Parent (9/30/08)
$140
Expected cash at Parent (12/31/08)
$210
2009 Annual cash needs
Interest expense
40
Debt repayment
35
Other
10
Total
($85)
Average dividends from subsidiaries
$100
Expected cash at Parent (12/31/09)
$225
Cash at Parent as % of cash needs (12/31/08)
(12/31/09)
2.5
2.6


90
2009 Cash & Investments Guidance
2009 Cash & Investments Guidance
Operating cash flow approximately 115% of net income
or $275 million to $295 million
Capital expenditures of approximately $50 million to 
$55 million
No share repurchases
Maintain strong capital position with a total RBC of
approximately 350%
Solid balance sheet, keeping debt-to-total capitalization
under 30%
Financial flexibility and liquidity


91
Summary
Summary
Visibility to 2009 earnings growth
Focus on margin improvement
Executing on G&A expense management
Investment portfolio and balance sheet strong
GRAPHIC 3 g31893ex99_1s10gbgd.jpg GRAPHIC begin 644 g31893ex99_1s10gbgd.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`+1`\$#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P`\9^*?$%OX MPUR"WUS5(H8[Z=$C2[D5542,```>`!60/%_B7_H8-7_\#)/\:3QW_P`COX@_ M["%Q_P"C&K%%>C&*LM#X2O6J*I+WGN^IN?\`"7^)/^A@U?\`\#)/\:7_`(2[ MQ)_T,&K_`/@9)_C6&*<*OE78YW7J?S/[S:_X2[Q)_P!#!J__`(&2?XT?\)=X MD_Z__``,D_P`:Q:3%'*NPOK%3^9_>;7_"7^)/^A@U?_P,D_QI#XO\2_\` M0P:O_P"!DG^-;7@CX=ZQXJ82HGV/3L9^U3*<-[(.K?RXZUZWI'P9\-6B#[<; MN_D[[Y/+7\`N"/S-93G3CH>EAL'C,0N:+:7=L\(/B_Q+_P!##J__`(&2?XTT M^,/$O_0PZO\`^!LG^-?0U[\(_"%Q`R16$UJYZ217,A8?]]$C]*\.^)/@>Z\& M:C$K2_:+"XR8)\8/'56'8C(^OYXF,X3=D:XC!XK#1YY2NO)LR#XP\3?]##K' M_@;)_C33XQ\3?]#%K'_@;)_\56*:8:OE1RQK3_F?WFT?&/B?_H8M8_\``V3_ M`.*II\9>)_\`H8M9_P#`V3_XJL0TPU/*C>-6?=FV?&?BC_H8]9_\#9/_`(JF MGQGXH_Z&/6?_``-E_P#BJPS334M(WC4GW-L^-/%/_0R:S_X'2_\`Q5-/C7Q3 M_P!#)K7_`('2_P#Q581IAJ6D;QJ2[FZ?&OBG_H9=:_\``Z7_`.*II\;>*O\` MH9=:_P#`Z7_XJL$TTU+2-XSEW-[_`(3;Q5_T,NM_^!TO_P`533XW\5_]#-K? M_@=+_P#%5@FFFIL;QD^YO'QOXK_Z&;6__`Z7_P"*I/\`A-_%?_0S:W_X'2__ M`!58!IM2;1DSH/\`A-_%G_0S:W_X'R__`!5!\<>+/^AGUO\`\#Y?_BJQ+2VG MO+F.WM(9)IY&VI'&NYF/L*]V^&WPB@MHDU#Q;"LUT3F.RW9C08ZOZM[=![]D M:ILX#PG>_$/Q3>>1I&NZZZ*<23M?2B./_>;/Z=:^B/!FBWNA:>JZAK>IZI?L M/WLUQ=2.O7HJ,Q``XYZ_GBMR-%C14C4*BC`51@`>E.I%DGGS?\]9/^^C1Y\W M_/63_OHU'12&2>?-_P`]9/\`OHT>?-_SUD_[Z-1T4`2>?-_SUD_[Z-'GS?\` M/63_`+Z-1TV@"7[1-_SUD_[Z-)]HF_YZR?\`?1J,TTT"N2FYF'_+:3_OHTTW M,Y_Y;2?]]&HR*3%`KLD^TS_\]I/^^C1]IG_Y[2?]]&H\&DH"[)?M,_\`SVD_ M[Z-'VF?_`)[2?]]&HJ*!7)?M,_\`SVD_[Z-'VF?_`)[2?]]&HJ*`N2_:9_\` MGM)_WT:/M,__`#VD_P"^C45%,+DOVF?_`)[2?]]&C[3/_P`]I/\`OHU%BEQ0 M%R7[1/\`\]I/^^C1]HG_`.>TG_?1J/!HP:079)]HG_Y[2?\`?1H^T3_\]I/^ M^C4>#1B@-23[1/\`\]I/^^C1]HG_`.>TG_?1IFVC`IAJ/^T3_P#/:3_OHT?: M)_\`GM)_WT:9BEH`D$\_>:3_`+Z-'VB;_GM)_P!]&F4VD*Y+]HF_Y[2?]]&C M[1-_SVD_[Z-144!=DOVB;_GM)_WT:/M$W_/:3_OHU%10%V2_:)O^>TG_`'T: M/M$W_/:3_OHU%10%V2_:)O\`GM)_WT:/M$W_`#VD_P"^C45)3"[)?M$W_/:3 M_OHT?:)O^>TG_?1J*B@+LE^T3?\`/:3_`+Z-`N9O^>LG_?1J&B@+LL_:)O\` MGK)_WT:/M$W_`#UD_P"^C4"FG&@+DOVB;_GK)_WT:<)Y?^>LG_?1JN*<*!W9 M-Y\O_/63_OHTOGR_\]7_`.^C40I10%R3SY?^>K_]]&CSY?\`GJ__`'T:CHH" MY)Y\O_/5_P#OHT>?+_SU?_OHU'10%R3SY?\`GJ__`'T://E_YZO_`-]&HZ*` MN2>?+_SU?_OHT>?+_P`]7_[Z-1T4!?+_P`]7_[Z-'GR_P#/5_\`OHU'10%R3SY?^>K_`/?1H\^7_GJ__?1J.B@+ MDGGR_P#/5_\`OHT>?+_SU?\`[Z-1T4!K_]]&HZ*`N2>?+_`,]7_P"^C2>?+_SUD_[Z-,HI MCN/\^7_GK)_WT://E_YZR?\`?1J.B@=R3SY?^>LG_?1H\^7_`)ZR?]]&HZ*0 M7)//E_YZR?\`?1H\^7_GK)_WT:CHH"Y)Y\W_`#UD_P"^C2>?-_SUD_[Z-,I* M87)//F_YZR?]]&CSYO\`GK)_WT:CHH"Y)Y\W_/63_OHT>?-_SUD_[Z-1T4@N M2>?-_P`]9/\`OHT>?-_SUD_[Z-1T4#)//F_YZR?]]&CSYO\`GK)_WT:CHH`D M\^;_`)ZR?]]&CSYO^>LG_?1J.B@"3SYO^>LG_?1H\^;_`)ZR?]]&HZ*`'^?- M_P`]9/\`OHT>?-_SUD_[Z-1TE,+DOGS?\]9/^^C14=%`'S%XZ_Y'?Q!_V$+C M_P!&-6**VO'7_([^(/\`L(7'_HQJQ17HQV1\'B/XDO5BBG"FBG59S,?%&\TJ M1PHSR.P5449+$]`!W-=IING67@V^LKKQEI,]U-/$)X+/(4(-Q`,@/4\?=_/T M&]\!/#CW^O/K?_L[5C*=Y\AZ M=+".EA?KCWOHNGJ>W>&M3BUG0;'4;>$P17$8=8SC*CICBN*\._%:RUOQ+;Z/ M%IMS%+-(T8D9U(&`3_2N1\)?%RQT/PWI^F2Z9=2O;1",NKJ`W-<;\*I!+\3M M)D`P'FD;'U1JP5&W,Y(]B>:G>/;.;5;GQC<26NI/]AMK M6"P$)D59)26)957[^TO[XYH^-D'D?"W3HM0E,E[%+`H=SEGD"$,?Q&XUZS7S MI\?O$Z:KKT.D6D@:VT_/FE3PTQZC_@(&/J6J:;C.3=W+3\6_P MO^!Y0:8:>:::ZV?-1(S333S3#4,Z(C#3#3C334F\1AIAIYIAJ3HB,-,-/--- M2SHB,---/-/M+6>]NHK:TADFGD;:D<:Y9CZ`5#-XE>NM\$>`-9\67"F"%K:P MZM>3(0F/]G^\>.WXXKTSX>_!Z*W\K4/%86:7[R6*G*+_`+Y[GV''UKV2.-(H MUCC5411M55&`!Z`5#9U0IO=G->"_!&C^$K?&G0;[IAB2ZEYD?\>P]A73T44C M:U@%+24M(`HHHH`****`$-)2FD-`#310:0&@!:*1NE)FF(=0*;NI0PH`=12; MA1N%(0M%)N%&X4`+13=U&ZF`ZBF[J,F@!U%,YHH`?1D4RB@!V11D4VB@0^EI M!2T`(Q[4E)2T@"BBB@`HHHH`***2F`4444"$HI:*`"BBEH`2G@Y%-H7K0`IZ MTHI&H%`QXI:04M`"T444`%%)10`M%)10,6BC-%`!1110`4444`%%%%`!1110 M`4444@"BBB@`HHHH`2B@T4QA1112`****`"DI:2F`4444`%%%%(84444`%%% M%`!1110`4444`(:2E-)3`7-%%%`SYB\=?\COX@_["%Q_Z,:L05M>._\`D>/$ M'_80N/\`T8U8@KT8[(^$KK]Y+U8\4N::*7-4<[1]3_!^RCLOA[I7E@;IE:9S MZEF/],#\*\Q_:+_Y&?3?^O/_`-G:M?X(^.K.'3H_#VK3+!)&S&UED.$9222A M)Z'.<9ZYQZ9](\0^#]`\37$-UK%D+J5(]B.)I$^7.?X6`/6N*_LZCZ[X:\%:3%:2WD%K;VX\N.W5S)(/;;DM^)KYX\1^(]'741/X.TA M]*D1F(O'N)&F.002!N*KP3ZGT(JZ;E+F\SFQM.CA_9--)QM=+=[>7YV/8?BQ M\1H/#UI+IFCS)+K4@VL5Y%L#W/\`M>@_$]L_-LC,[,SL69CDDG))I9'9W9G8 MLS')).233#6L(*"LCS<5BYXN?-+;HAIIAIQIIIF44,---.-,-2S>(PTTTXTP MU+.B(PTTTXTPU+.B(TTTTXUZ/\,_AK=:_<0ZAK$+P:,"3M8E7GXXV^BYQS^5 M0W8Z:<7)V1R?A?P?K?B=F_LBR:2%6`>=V"1K^)Z_09-?0OP\^'UAX/C,^\W6 MJ2)MDN&&`H[JH[#CZFNOLK2WL;6.VLX(X+>,;4CC4*JCZ"IQ63E<]&G14->H MM)2TE2:A1113$+1112`****`"BBB@!#2&E-)0`TTWH:<:::`%ZBFGBE4\TM, M0VBE(Q24A!1110`4444`%%%%,!11112$%%%%`!1110`444HZTP'BD;I2TC=* M`$HHHI`%%%%`!1110`E%%%,044E+0`444M`!1110`4=Z*0T`.;I2"E/W::*` M)`:4&F`THH&/S2&DS24"'4F:2B@8N:7--HH`?FBF@TH-`QV:*2E%`!1110`4 M444`%%%%`!1110`4444@"BBB@!#12FDIC"BBB@`HHHI`%)2T&@!****8!111 M2&%%%%`!1110`4444`%%%%`"4E+24P"BBB@#YA\=G_BN/$/_`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`_&%KJ^ESV=P;=H1_9&YA)&&@YHK9Z5`99>K,>%C7U8]A7T;X"\":=X2M]Z M`7&I.N);EAS[A1V'\^]9RE8[J%"53T.4\!_"*'39UO?$KPWDZ',=M'DQ*?5B M0-Q]NGUKUH````8`["BBL6[GJPIQ@K1"E%)2BD4+24M)0`44E**8A:***0!1 M110`4444`%)2T4`--,(I](:`(R*4'UI332*8A])MI%/K3Z`8S::,>4A$># M1BI**`(\&EP:?13`9@TN#3J*`&X-J*`&X-Y%)NH`-M*!BDR:`:!#Z1 MNE+0>E(!M%)2T`%%%%`!1124P"BBDH$+112T`%%%%`!1110`4=Z*510`/]VF M"ED--H&/'-.Z"@<"HW;-`A2_I2%R:;10`9-.#$4VEQ0!(&!I:BQ3U/8T#'4` MT4AX-`#P:6F`TX4#'"BDI:`"BBB@`HHHH`****`"BBBD`4444`%)2TE,8444 M4`%%%%(`HHHH`2BBBF`4444`%%%%(84444`%%%%`!1110`4E+24P$HHHH`^7 M?'A_XKCQ#_V$;C_T8U=5\1-=#:+X.BTK5`3#I,4S1I]=EKI_5DOT/=/!=QH-KHOAV70]0\-V5PDB/JKZFRK=$@J6$98< M#[V.G;D'-5=,UO2QXL^(D[:C9K#=VDBV[M,H$QVGA"3\Q^E>+9I,T>S\P6-: M44HK3_*QZAYUCKOP:L=/CU2PM;_1YIKB6"YEV/*O[Q@(Q_$3O4`>O>L[XG:A M:7FC>#([.[@N&M])BCE6*0.8W"KE6`/!XZ&N`S2$TU&SN9RQ#E#EMT2^[8]1 M^*^J6%]X^\.W-E?6MQ!':6RR2Q2JZHPE!?` MVH^+;@F(FUL$R'NG3<,^BCCX^GHOO^5? M0-E:P6-I%;6<*0V\2[4C08"BLYSMHCOPV$<_>GL9_AKP_IWAS35LM+@$YK6HHK`]9))604444`%+24M`"TE+24`)2BDI13$+1112`****`"BB MB@`HHHH`0TE.I#0`TBFD4\TAIB(R*53BEQ2$4@'TTM0I[4$>E`@W>U&[VIM% M,!V[VHW>U-HH`=DT9-)12$'-%%%`!1113`*6DI:`'+TI:1>M+2`;T-%*P[TE M`!1110`4E+24P"BBDH$+2TE+0`4444`%%%`&:``#/TIU%-G_BNO M$7_81N/_`$8U80-;?CX_\5UXB_["-Q_Z,:L+-=D7H?*58^^_4?FES4>:7-5< MQY1^:,TS-&:+ARCLTF:;FD)HN-1'$TTFD)I":5RU$4FF$T$TTFE[?YX+>1 M<"(9X9@>I/4>G'?IZW6$ZG1'KX7!JW/4^X9;PQV\$<$"+'#&H1$48"J!@`>V M*?116)Z84444""BBB@`I124HH`6DI:0T`)2BDI13$+1112`****`"BBB@`HH MHH`****`$-)3J0TQ#<4A%.I"*`&$4H-*1332`<1FFE:56[&G4Q$=%24F!0`V MBG;11@4"&T4[`I<"@!E%/HH&-P:4`TN:3=0(4#FEIN31DT`.II@YI3S2` M;10>**`"DI:2F`E+124"%HHIRB@!`":7;2T4`(`!2T4TMCI0`K'%1G)H)S10 M,3%2KT%1U*.E`B.0!312YH`#244JC)H&!%(>E M*W6FN<"@!HIPI@IPH&/%.I@I:7-.YERC\T9IF:,T7%RCLT9IN:3-%RE$7-)FD)H4%F" MJ"6)P`.II7*422V@FNKB."VC>6:1@B(@R6)Z`"O=_!'PJL+/3A+XDB^TW\HR M8UE95B'IE2,GU/3^=6?A#X'_`+"L/[2U:V4:M-]P-R8(R!QCLQYS[8'K7I%8 M3J.^AZ^&P4>7FJJ]^AR?_"N_"W_0+_\`)B7_`.*H_P"%=^%O^@7_`.3$O_Q5 M=914^TEW.CZEA_\`GW'[DTEW#ZEA_^?%O\`H%_^3$O_`,51_P`*[\+?]`O_ M`,F)?_BJZVDH]I+N'U+#_P#/N/W(Y+_A7?A;_H%_^3$O_P`51_PKOPM_T"__ M`"8E_P#BJZRE%/VDNXOJ>'_Y]Q^Y')_\*Z\+?]`O_P`F)?\`XJC_`(5UX6_Z M!?\`Y,2__%5UM%+VDNX?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*/:2[A]3P__/N/W(Y+_A77A;_H%_\`DQ+_`/%4?\*Z\+?] M`O\`\F)?_BJZVBCVDNX?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*/:2[A]3P__/N/W(Y+_A77A;_H%_\`DQ+_`/%4?\*Z\+?] M`O\`\F)?_BJZVBCVD^X?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*?M)=Q?4\/_P`^X_'_Y]Q^Y'(GX=^%O^@7_`.3$O_Q5-/P[\+_] M`O\`\F)?_BJZ\TA%'M)=P^IX?_GW'[D<@?AYX7_Z!G_DQ+_\52?\*]\,?]`S M_P`F)?\`XJNN(II%'M)=P^IX?_GW'[D>%O^@9_Y,2__ M`!5'_"O?"W_0+_\`)B7_`.*KJJ*7M)=P^IX?_GW'[DTEW%]3P_P#S[C]R.4_X5YX7_P"@9_Y, M2_\`Q5*/AYX7_P"@7_Y,2_\`Q5=52T_:2[A]3P__`#[7W(Y3_A7GA?\`Z!?_ M`),2_P#Q5'_"O/"__0+_`/)B7_XJNLHI>TEW#ZGA_P#GVON1R?\`PKSPO_T" M_P#R8E_^*I1\//"Q_P"87_Y,2_\`Q5=72K1[27'_`.?:^Y'*?\*[\+?] M`O\`\F)?_BJ0_#OPO_T"_P#R8E_^*KK:0G%'M)=P^IX?_GVON1R7_"O/"_\` MT"__`"8E_P#BJ/\`A7GA?_H%_P#DQ+_\576'FDI^TEW#ZGA_^?:^Y')_\*\\ M+_\`0,_\F)?_`(JC_A7GA?\`Z!G_`),2_P#Q5=924>TEW%]3P_\`S[7W(Y4? M#SPO_P!`O_R8E_\`BJ=_PKOPM_T"_P#R8E_^*KJ:?1[27'_Y]K[D'_Y]K[D'_`.?:^Y') M_P#"O/"__0+_`/)B7_XJC_A7GA?_`*!?_DQ+_P#%5UM%'M)=P^IX?_GVON1R M:_#SPN3_`,@O_P`F)?\`XJG?\*[\+?\`0+_\F)?_`(JNL'2D)`-'M)=P^IX? M_GVON1RG_"N_"W_0+_\`)B7_`.*J,_#WPP#_`,@S_P`F)?\`XJNPI&7-'M)= MQ?4\/_S[7W(Y`?#WPO\`]`S_`,F)?_BJ>/AYX6[Z7_Y,2_\`Q5=1@@\TX4>T MEW#ZGA_^?:^Y'+?\*[\+?]`O_P`F)?\`XJC_`(5WX6_Z!?\`Y,2__%5U8IPH M]I+N'U/#_P#/M?M+VDNX?4\/\`\^X_'_Y]Q^Y'*_\*[\+?]`O_P`F)?\`XJD_X5YX5_Z! M?_DQ+_\`%5U=%'M)=Q?4\/\`\^U]R.4_X5YX5_Z!?_DQ+_\`%4?\*\\+?]`O M_P`F)?\`XJNJI*/:2[C^IX?_`)]Q^Y'+?\*[\+?]`O\`\F)?_BJ/^%>>%O\` MH%_^3$O_`,5759IU/GEW#ZGA_P#GW'[D'_P"?%?^@7_P"3$O\` M\51_PKKPK_T"_P#R8E_^*KK:*7M)=P^IX?\`Y]Q^Y')?\*Z\*_\`0+_\F)?_ M`(JC_A77A7_H%_\`DQ+_`/%5UM%'M)=P^IX?_GW'[D%O^@7_Y,2__`!5=;13]I+N'U/#_`//N/W(Y+_A77A;_`*!?_DQ+ M_P#%4?\`"NO"W_0+_P#)B7_XJNMHI>TEW#ZGA_\`GW'[D%O^@7_P"3 M$O\`\51_PKKPM_T"_P#R8E_^*KK:*/:2[A]3P_\`S[C]R.2_X5UX6_Z!?_DQ M+_\`%4?\*Z\+?]`O_P`F)?\`XJNMHH]I+N'U/#_\^X_%O^@7_P"3 M$O\`\51_PKKPM_T"_P#R8E_^*KK:*/:2[A]3P_\`S[C]R.2_X5UX6_Z!?_DQ M+_\`%4G_``KOPM_T"_\`R8E_^*KKJ2CVDNX?4\/_`,^X_UC>6>5@J(@R6)[`5]%_#?X>VGAVSCNM3ABN= M7?#%F4,(/9/?U;^E4?@[X&DT&U;5=7A4:C<*/*C8?-`G?Z,<\^F,>M>FUC.= M]$>KA<*HKGGN%%%%9G>%%%%`!1110(****!!1110`4M)2T`+2444`%%%%,0M M%%%(`HHHH`****`"BBB@`HHHH`****8@I:2EH`0TE.I,4@&D4TBGTA%`$9%) M4A%-(I@*IS013>AIP.:!"8-)3Z*`&44[`HP*!#:!3\44#$P:7;2T9H$&!12; MJ4*`"F._84C-G@=*90, M*4M8'P3\#7%M=-KNM6IB*KMM89 MD(8'/,F#TXX'U)]*]HK.WOR"BBBLSN"BBB@`HHHH`****!!1110( M****`"BBB@!:*!10`444E,0ZBDI:0!1110`4444`%%%%`!1110`4444Q!2BD MH%`"T444@"DI:*`&D4TBGTA%,!F*0T_%)BD`S)%+N]:"*0B@0[<*6HL5*.E, M`I"WI2'K24`+2TE+0(*5>E)2KTI`#=*2E;I24`%%%%`!24M)3`*!P:**!#P< MT$9IE*&H`7%�"#2T``I&.!2GBH^IH`44X4@IPH`44X4@IPH`6F.)O^PG<_\`HUJY[-:IGGRCJQ^:,TS-+FBY/*.S7LGP M9^'YN7A\0:U$/LZ_-:0./OGM(1Z>GKU^O,_";P1/XDUBWO;ZT9M"A<^:[-M$ MC`<(.YYQG';/.:^F418T5(U"HHP%48`'I4RET1T4*-WS2%I:2E%9':%%%%,` MHHHH`****`"BBB@04444""BBB@`HHHH`44M(*6@!*2EI*8A:6D%+2`****`" MBBB@`HHHH`****`"BBBF(*!110`M%%%(`HHHH`*2EHI@-Q1BEQ10`PBD(IY% M(12$1XYI])CFEI@-/4TE*>II*!!2TE+0`M*O6DH[T@'4VG4T\&@`HHHH`*** M*`$HI:2F`E%+10(2GK30,FGDX%`#'/.*!2=3FG"@!13A2"G"@!12]!0*1CVH M&-)S244US@8H`8QR:!0*44#"EI:!UH`=2-VI:1NU(0E%%%`!1110`4AHH-,! M****`"BBBD`4444`%%%!H`<#D4AX-(IYIQ&13&`-.%1BG@TACZ6FBE%`"TE+ M24P"BBB@`HHHI#"BBB@`HHHH`****`"BBB@!#24II*8"T444#/D#XBG_`(N! MXF_["=S_`.C6KGLUT'Q&/_%P?$W_`&$[G_T:U<[FK1R26H_-=3\//"-UXOUQ M+:,.EE$0US.!]Q?0?[1[?GVK#T#2KK7=9M-,L5!N+F0(I.<+ZL<=@,D^PKZT M\&>&;+PKH<6GV*@L/FFE(^:5^['^@["DW8<*?,]33TK3[72=.@L;")8;6!=B M(.P_Q]ZM&BBH.M:"4444BA:***8@HHHH`****`"BBB@04444""BBB@`HHHH` M6EIM+0`4E+13`!2TVG4""BBBD`4444`%%%%`!1110`4444""BBBF`HHI!2T@ M"BBB@`HHHI@%%%%`"&D-.III"&]Z***8#3UI*5J2D(*6DHI@+2TE%`#EZ4I& M130<&G4`-HI2,TE(`HHHH`****`"DI:`,FF`JCBFLIR*92@X-`"MU MS0*4\BFBD,D%+3`:>*`%HI.]+3`****`"BBBD,****`"BBB@`HHHH`***2@` MHI*6F`4444#/CWXC'_BX/B;_`+"=S_Z-:N>4%F"H"S$X`'))K?\`B/\`\E"\ M3_\`83N?_1K5ZC\%/AS_`,>OB76U_P!NTM67Z;96_7`QZ&G#0`E%%%`@I1244`.I5--HI`/I"/2@-ZTM`#:*<1FDQ0`E%%)0`4 M\#`I`.](YQP.M,!"E(PYS2*<&G$9%(!!3J8*<#0,=2T@I13` M6BBB@`HHHI#"BBB@`HHHH`****`"DI:2@!*6DI:8PS12T4@/F(^$I_&'QD\1 MV:;DLX]3N9+F8?P)YK<#W/0?GVKZ:151%5%"JHP`!@`50TS0K+1;O5'LD/F7 MUY+=SR/@LSNQ.,@=!G`':M"@:5@HHHH&%%%%`"&BE-)2`444"BF`4444`%%% M%`!1110`4444""BBB@04444`%**2EH`6D-+24`)2T4E,0ZBBBD`4444`%%%% M`!1110`4444`%%%%,04444`+1112`****`"BBBF`AI#2TTT`(:0=:4TF*0A: M",T4F:8!M%&!110`8%&T444`)BCI2YI:`&TH.*,4E`AX.:*;0#2`=1B@'-%` M`3@5'U.:5SGB@4P%%.%(!3A0`"G"@4$XH&(YYQ3:*1C2$(>M%%%`!1110`44 M44`%)2T4`%%%)0`444E,`HHHH`****0!1110`4444`%)113&%%%.4=Z`&T4K M=:2D`4]3D4RE4X-``W!H!I6Y%-!IC)!2TT4X4`.HI!2TAA1110`4444`%%%% M`!1110`4E%)3`6BBEH&%%%%(!]S_`,?,O^^?YU%4MS_Q\R_[Y_G45!3"BBB@ M`HHHH`*2EI*`"EI*6@`HHHH`****`"BBB@`HHHH$%%%%`@HHHH`****`%I:2 MEH`2DI:*8`*6DI:!!1112`****`"BBB@`HHHH`****`"BBBF(*6DI:`"BBBD M`4&BDH`0TAH-)3`**0T4""BEHH$)11UH-`PHHQ10`8I*6B@`H(!HHH`3I2T= M12=*!"CK2L<"A>F:83DT``IPI!3A2`44X4@IPI@'2FGFE;TIM`!3:5J2D`44 M44`%%%%`!1124`+2444P"DHHH`***4CTH`2BBBD`4444`%%%%`!1124P"BBC MK0,4#)I](!BEI`,;K24K=:2@`HHHH`<.133P:53VI6'%,8"G"HQ3Q0`ZG4T4 MHI#%HHHH`****`"BBB@`HHI*`"DHI:8!2TE+2&%%)10!)<_\?,O^^?YU%4MU M_P`?,O\`OG^=14%,****`"BBB@`I*6B@!*44E%(8M%%%,04444`%%%%`!111 M0(****!!1110`4444`+124HH`**6DI@)2TE**!"T444@"BBB@`HHHH`****` M"BBB@`HHHIB"BBB@!:*04M(`---+2&@!IHHHH$)BBEHI@)2FBCO0`"BBB@!! M2T4E`A:3%+12`2BEI*8P[TM)2GB@!KGBFBCJ:44"'"G"FBG"@!PI#FBF9YI],844$XINZ@!U%-W4XD(****`"BB@T`%1R$AN*DIDHXS3`52&%)TJ-3@Y MJ4\C(H`2BDI:0@I5'>DI6.!3`1CDXH%(*<*`%%.%(*<*!BBFLE)2$.!I:913`?13**!C\TF13:*`'9%&: M;10(?36[4X=*1NE`QM%)10`5(.E1T\=!0`C=:;3GIM`!3E/--H'6D!)4=24Q MNM`"4444`.7I0>E(.M.IC&4E*>#24A!2T44#`<&G'D4VE4T`(*<*:PP:44#' MBG"F"G4`.HI*6@`I#2TE`"4M)2TQA12TAI`)1110`4444`27/_'S+_OG^=1U M)<_\?,O^^?YU'2+"BBBF(****`"BBB@`I*6B@!*6DHI`+1113`****`"BBB@ M`HHHH`****!!1110(****`"EI**`'4E%+0`E)2TE,!:6DI:0@HHHH`****`" MBBB@`HHHH`****`"D-+2&F(::::<:::`%H[T44`+1112$%%%%`"=Z&&012T4 M`5SQ4D;=J20O2E/2F+UI]`$=%*PYI*`"GKTIE.7I2`5N13*DJ.@`HH MHH`>O2D>A32GF@!E%%%`!3J;2J:!@PI*?3*`"BBB@`I`<&BB@!Y&1313E.13 M6�,<*<*8*<*`'BEIM+0`4E+13`*6DI:0PIM+24`%%%%`!1110!)<_\?,O^ M^?YU'4EU_P`?,O\`OG^=1T%A1112`****8@HHHH`****`$HI:2D,6BD%+3$% M%%%`!1110`4444`%%%%`@HHHH$%%%%`!1110`M+3:44`%%+24P$I:*2@0ZBD MI:0!1110`4444`%%%%`!1110`4AI:0T`(:8:>:::!"#I2TT=:=3`!2TE+0`4 M444A!1110`A&1BH6&#BIZ:R[J`&1'G%2U&J$-3G/%`#"*=0W2@! MM)110`4444`%%%%``.M25&.M24`(PR*94E,88-(!*>13*M,!M*IQ2'`[T4`244U>E.H`3%&*6B@!,4&@FB@ M`H'(HH%`#** MM/H`81BDJ0TS!H`53Q2TU13J8QI%)3CTIM(04H/-)24`24PC!IPY%#"@8VBB MB@`!P:?4=.4\4#$81D4R@`HHHH$%`X-%%`#^HIO0T*>U#>M`Q0:<*8* M<*8QXIU-%+2`*2BB@`HHHH`****`"BBB@"2Z_P"/F7_?/\ZBJ6Z_X^9?]\_S MJ*@L*6DI:`"BBB@04444`%%%%`!1110`E%*:2D,6BDI:8@HHHH`****`"BBB M@`HHHH$%%%%`@HHHH`****`"EI**`'4E%+0`E)2T4P"EI**!"T444@"BBB@` MHI*2@!*2GD9%,H`*`<&BB@"2FL.]*O2EH&1T4K#!I*!!11 M10`4[J*;0.M`PZ&G"@BD!IC)`:*:#2BD`ZBD%+0`4444`%%%%`!1110!)=?\ M?,O^^?YU%4MU_P`?,O\`OG^=14%A2TE%`"T444@"BBBF(****`"BBB@`I*6B M@!*44E%(8M%%%,04444`%%%%`!1110`4444""BBB@04444`%%%%`"T"DI:`% MI**6@!***2F`M+244"%I*6DI`)2$T&DH`***6@`Q1110`M&*2EH`,4VG4C=* M!"4444`+12"EH`****8!1110`AHI:2@`S2TE+0`GX48'I2T4A"8'I1Q2T4`) M1S2T4`%&***`"@T44`)10:*``4,<"@5&[9.!0`A.>M%%+0,3%+BEQ2XI@)BC M%.Q2@4`-Q2XI<4N*`&XHQ3\4F*`&8I"*DQ32*`&8I.1TIY%(12&`;UIP.:9B MD^E`$M)30V.M.!!H$(1Z4+FG44#"FL,TZB@".BG,/2FT"%!P:?4=.4]J!BD9 MIAE(>10`RBBB@`HHHH`4&@\4E.ZB@8@-.!IG2E!H&2"E%,!IU`A:*!10` M4444`%%%%`R2Z_X^9?\`?/\`.HJENO\`CYE_WS_.HJ"@HHHH`6BDI:0!1113 M$%%%%`!1110`4444`)12TE(!:*2EI@%%%%`!1110`4444`%%%%`@HHHH`*** M*!!1110`4444`+2TVEH`**6DH`*2EI#3$&:#24F:`"@44H%(!11110`4444` M%%%%`!112$T`)1110(*4=*2@'%`#L4E+10`E%+BDH`****8"4"@T4`+1110` M4444@"BBB@!**6DI@%%%)0`4M%(3B@!'/:F4=:4"@8`4X"@"G`4"$`I<4HI: M`$Q2XI:,4`)2TM%`"8HQ2T4AC:,4ZDQ0`W%)BG48H`9BFXJ0BD(H`C(I,5(1 M3<4`-R12[C1BC%`!O-.#`TS%)0,FI",TQ6QUI]`AI4TH%.I*`"DHHI@!%-/% M.HH`;101BBD`4#BBB@!W6DQ2`\TXT#`4X5'FGB@!U+313A0`4444#"BBB@9) M=?\`'S+_`+Y_G452W7_'S+_OG^=14#"BBB@`HHHH`6BBBD`4444Q!1110`44 M44`%)2T4`)2TE%(8M%%%,04444`%%%%`!1110`4444""BBB@04444`%%%%`! M1110`M+3:6@`I#2FD-`#33:4TE,0Y:=2#I2B@`HHHI`%%%%`!2$T,>*2@`HH MHH`***2@!:*0$&EH`4&EIM.'2@04444`)12TE`PI*6@T`(*6DH%`A:*3-&:` M%HI.:*`#-%%%`!12$@=33"_I3`M`"!<4C'G%!;TIHH`<*<*:*<*!CA3A313A0`4444#"BBB@" M2Z_X^9?]\_SJ*I;K_CYE_P!\_P`ZBH&%%%%`!1110`4M)2B@`HHHI`%%%%,0 M4444`%%%%``:2EI*0!2TE%`"T444P"BBB@`HHHH`****`"BBB@04444""BBB M@`HHHH`***#0`4A-!IIH`#2KUIM/7I3`**6C%`"4M&**!!112-TI`)UHHIKM M@>]``S`4SS#FF$YZTJ#+4`3#I37/:G$X%1]3S0`"I`O2F5(O2@`HHI:`$HI<48H`2 MFMUI]1MUIB#-0LO2@0M+244`+2TVEH`*C/6I:C<U)1WH8X&:`$9@M*#D5"3DU M+']P4`.I5[TE*M`"T444`%(:6B@!*0TM(>E`"'I4535%WH`<*<*:M/%`"BEQ M0*44`)2XI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**3-& M:`"BDI:8"44M%`!12T4AA1244`%%)10`4444`%%%%`!1110`48HHH`,48HHH M&%%%%`PHHHH`****`"BBB@`HHHH`DNO^/F7_`'S_`#J*I;K_`(^9?]\_SJ*@ M84444`%%%%`!1110`4444`+124M(`HHHH`****8@HHHH`****`"DI:*`$HHH MI#%HI*6F(****`"BBB@`HHHH`****`"BBB@0&D-*:0T"&FD%*::*!BT]*93E MZT"'4444`%%%%`"TUN12T4`1T4I'I3`:QR?:@4@IPI"%%+124P"HY6R<4 M]C@5#U-`!4T?W!40&3BIAP,4#'4X<"F@9IU(04444`%%%%``::>E.I&H`2H^ MYJ2H^YH`44\4Q:>*`'"G4T4Z@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI M*,T`+244E,!:*2EH`2BEHH&%%%+0`E+124@"BBDH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH&%%%%`PHHHH`****`"BBB@`HHHH`**,T4`277_'S-_OG^=15 M+=?\?,W^^?YU%2&%%%%,`HHHH`****`"BBB@`HHHH`6BDI:0!1113$%%%%`! M1110`4444`%)2T4`)1112&+124M,04444`%%%%`!1110`4444`!I#12&@0TT M@ZTIIN>:`'4HZTE%`B2BD7I3L4#$HI<44`)13J2@!K#C-,/2I<5&PP:!#!3A M1THH`6DHHI@1R')IH&:DV#/-.`QTI`(JX^M.`S2A?6GXP.*8"`8%!HHI`)12 MTE,04M)10`M,SS2GI3:`%-1]Z,4P4`.%.%-% M/%`#A3A312T`.%+24E`#J*2B@!:2BB@`HI**`%HI**`%S1244`+2444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110,****`"BBB@84444`%%%%` M!1110`4444`%%%%`!2444AA2T44Q!1110`4444`/NO\`CYF_WS_.HJENO^/F M;_?/\ZBI%!1110`M%)2T`%%%%,04444`%%%%`!1110`4444`%+244`+1112` M****8@HHHH`****`"BBB@`I*6B@!#29HIII#`FDHHIB%`R:D'%-08IU`!111 M0`4HI*44`%%+10!"1@XI*?)UIE`A5.#4U05)&A[4CCG--H`DHINXT;CZ4`.HIFXT9-`#\BD+>E,HH`4G-)110`4C'`H9L M"H^IR:`#J:4"@4X4#%`IPI`*<*!"BE%(*6@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH&%%%%`!1110,**** M`"BBB@`HHHH`****`"BBB@`HHI*`"BBBD,*6BBF(****`"BBB@`HHHH`?=?\ M?,W^^?YU%4MU_P`?,W^^?YU%2*"BBB@`I:2B@!:***!!1113`****`"BBB@` MHHHH`****`"EI**`%HHHI`%%%%,04444`%%%%`!0:*2@!#332FFT`%*!DTE/ M7I0`M+244@%HI*6F`4ZFTO:@!::7`ICMG@=*;0`I.3FDHHH`*53@TE%`B>BF MH>M1-]Z@0N M\TF2:2E%`"8I<4H%.Q0`W%+BG8I<4`(!2@4N*7%``!2T4M``****!!1110`4 M444`%%%%`!1110`4444`%%%%`!1110,****`"BBB@`HHHH`****!A1110`44 M44`%%%%`!1110`4444`%%%%`!1110`444E`"TE%%(844M%`@HHHI@%%%%`!1 M110`4444`%%%%`!1111<+#[K_CYF_P!\_P`ZBJ6Z_P"/F;_?/\ZBI%!1110` M4444`%%%%`!2TE%`"T444Q!1110`4444`%%%%`!1110`4444`%+244`+1112 M`****8A*::=330`TT444`*O6GTQ>M/H`6B@44`%%%%`#7Z4RGOVIE`$<4VE7[PH`FHHHH`****`$- M)2TE`$;?>-1OU%2-]ZF-TH$-%.%(*<*!@!3@*`*=0`F*7%%+0`48I:*`"BBB M@`HHHH$%%%%`!1110`4444`%%%%`!1110`4444`%%%%`PHHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHI*`%-)112&%%%+0(2EHHI@%%% M%`!1110`4444`%%%%`!1110`4444AA1110`^Z_X^9O\`?/\`.HJENO\`CYF_ MWS_.HJ!A1110`4444`%%%%`!1110`M%)2T`%%%%,04444`%%%%`!1110`444 M4`%%%%`!1110`M%)2T`)333J::0#:*.]%,0J]:?3!UI]`!2TE**`"BBB@!'Z M5'4IZ5%0`4PG)IS'`IHH$*!3J04M`!29&<4CM@<=:;$.]`R2G)]ZFU(@P,T` M/HI*,T`+24E%`!1110!&WWC36Z4X]::>E`#13Q3!3Q0`X4ZD%**`%Q1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1124`+2444AA112T`)2T44Q!1110`4 M444`%%%%`!1110`4444`%%%%`!1112&%)113`****`)+K_CYF_WS_.HJENO^ M/F;_`'S_`#J*D,****`"BBB@`HHHH`****`"BBB@`I:2B@!:***8@HHHH`** M**`"BBB@`HHHH`****`"BBB@!*0TM--`"&B@T4@"GCI3**:*<*`'BE%(*<*`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBDH`6BDHI`%%%%`PHI:*!"4M%%,`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHI#"BBDI@%%%%`!1110`4444`277_'S-_OG^=15+=?\`'S-_ MOG^=14AA1110`4444`%%%%`!1110`4444`%%%%`!2TE%`"T444""BBBF`444 M4`%%%%`!1110`444E`!332FFF@!IIU)BEH`*4'!I**0$E%(IR*6@`HHI:8@H MI*6@"-A@TE/<<9IE`!3@II4%.H`0*!2T44`%%%%`!1110`4E+10`AX%1TYCF MFT`(QP*C%*QR:`*0"BGBFBGB@8X4HIM.H$+1244P%HI*6@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI**+@+1244@%I***!A1110`4 M4M%`A**6BF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%(`HHHH&% M)113`****`"BBB@`HHHH`**B^T0_\]H_^^A14\\>Y7)+L6;K_CYF_P!\_P`Z MBJ6Z_P"/F;_?/\ZBIB"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I:2B M@!:***`"BBBF(****`"BBD-`!2&@TAH`0T44X"@``H(I:*`&44K"DH`53@T^ MHZ>IH`6BBBD`4444""F,,>C#BF`B=<4^HQQS4F:`"BC-&:`"BBC-`!11FD MS0`M,8YXH9L]*;0`4USQBG$XJ/J!0``4X"@4X4`)2THHH`2BEH MH`2BEHI`)12XI*!A11BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI:*!" M44M%`"44M%,`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH&%%%%(`HI**8!1110`4444`%%%%`!1110`5D>*+_`.PZ6X4XFF^1/ZG\ MJUZ\Z\37YOM4DP3G.,^JX9\OQ2T7ZL]+*L+]8KJ^T=69^T M>E%+17P=D?97/6+K_CYF_P!\_P`ZBJ6Z_P"/F;_?/\ZBK]1/SP****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`I:2B@!:*2EH`****8@I*#2&@!#2 M44"@!0*=112`****8!3*?33UH`2BBB@!X-+3%]*=0`M%&:*0!1110`P\&E4] MJ'IM`B2BF[C1NI@.HINXTE`#BPII.:2B@`H)Q2%@*8230`$Y-**0"G`4`*!3 M@*0"G@4``I112T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%(84444`%%)13`****`"BBB@`HHHH`****`"BBB@`HHJO?WD-C M;-/<-M0<#U)]!4SG&$7*3LD.,7-J,5=LR_%6I_8;+R8FQ<3#`Q_"OK'@?W1V%5L5^=YICGC:[FOA6B]/^"?Y-11BBN0Z3 MUBZ_X^9O]\_SJ*I;K_CYF_WS_.HJ_4#\]"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@!:*2@T`%--*:::!!2BDI1TI@**6FTN:0"T M444`(>E-I3S3)-<#))9V1.<[9)!TQZ"N6"U\AGN9*M_LU)Z+=_H?3Y/@'2_?U%KT7ZD M>VC;4H6G;:^;Y3WN8-M%3;316W*8\QZ==?\`'S-_OG^=15+=?\?,W^^?YU%7 MZ8?`A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4A MI:2@!#3:4T@H`6E'2FTX=*!!1110`HI&-%!ZT`-)P":9&,G)IY&1BD8X&!3` M1CV%.7I3!3UZ4"%I5I*5>M`QU%%%`!1110`4RGTR@".0IKYS-\U2BZ%!Z]7V\CW@!:44E`ZTQ#J*2EI`%(>M+2&@`J,\FGL<"F"F(4"GT@%+0` M4JT@&:?0,****`"BBB@!#3:5C24`,?J*04/UH%`#A3A2"G"@!12T4M`"8I<4 M44`%%%%`!2TE%`"T4E%`"T4E+2`****`"BC-%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%&:`"BBB@`HI**8"T4E%%@%HI**`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHIDLB0QM)*P1%& M22>!2;25V"3>B'USOB36##_HMFX\PY$C#^'V'O5+5?$*Q&R(\>8?O'Z> ME8:#/)ZU\QF>$K50,W,BV459V45KR&7.===?\`'S-_OG^= M15+=?\?,W^^?YU%7W!\B%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!332FD-`#33>].--QDT`.HHHIB%HI!2T`+2&BB@!K=*1:<: M*0"T#FBEH`7-+3:*`'44F:,T`+1132>U``>M)136.!3`8>M.%-%/%`#A3A2" ME%`#A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`+2444`+2444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445SNN>(XK96AL M6$EQTWCE4_Q-WJ?8"N) MUG69=38(!Y=NIRJ=R?4UG75W/>R^9=2M(_3)[?0=J:@KX_,,XJ8O]W#W8?B_ M7_(^HP65PPOOSUE^"]!Z"IT6F(*L1K7F01WR8Y%J=%IJ+5B-:ZH1,)2!%J=5 MI46ID2NF,#"4ABI3PE3*E2!*V4#%S(=M%6=GM16W(9\YN77_`!\S?[Y_G452 MW7_'S-_OG^=15]8?-!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!2&EIM`!2&@TE`!BBEHH$)12TE,`I:2@4`+1110`AHI:2@!12TE%`"T M4E+2`**,TF:`%)I***8!4;')H8YI!0`HIXI!3A0`HIU(*44`+1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4455OK^VL4W7,RIZ#N?H*B=2-./--V14(2F^6*NRU5 M74+^WL(#)<2!>.%[M[`5Q^J>)[JYREH/L\7J#\Y_'M^%8,TLDSEYI'D<_P`3 ML2:^[ALCG*TJSLNW4U]8\075_NC0^3;G^!3R?J:QU MIM.6OE*V(J8B?/5E=GTE*C3H1Y*:LB1!4Z#FHDJ>,41029*@JQ&*BC%6(Q75 M!'/)DT8JQ&*BC%6HQ77!'--CT6K"+3(Q5E%KKA$YI2!5J4)3D6I56NB,3!R( MMM%6-M%;>>(O^0W<_6BBOG^(OX$?7]&>WD?\`&EZ?J9U% M%%?'GTX4Y:**:!DRU+'VHHK:!C(L)5F*BBNF!SR+"59CHHKL@ GRAPHIC 4 g31893ex99_1s11gbgd.jpg GRAPHIC begin 644 g31893ex99_1s11gbgd.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`+1`\$#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P`\9^*?$%OX MPUR"WUS5(H8[Z=$C2[D5542,```>`!60/%_B7_H8-7_\#)/\:3QW_P`COX@_ M["%Q_P"C&K%%>C&*LM#X2O6J*I+WGN^IN?\`"7^)/^A@U?\`\#)/\:7_`(2[ MQ)_T,&K_`/@9)_C6&*<*OE78YW7J?S/[S:_X2[Q)_P!#!J__`(&2?XT?\)=X MD_Z__``,D_P`:Q:3%'*NPOK%3^9_>;7_"7^)/^A@U?_P,D_QI#XO\2_\` M0P:O_P"!DG^-;7@CX=ZQXJ82HGV/3L9^U3*<-[(.K?RXZUZWI'P9\-6B#[<; MN_D[[Y/+7\`N"/S-93G3CH>EAL'C,0N:+:7=L\(/B_Q+_P!##J__`(&2?XTT M^,/$O_0PZO\`^!LG^-?0U[\(_"%Q`R16$UJYZ217,A8?]]$C]*\.^)/@>Z\& M:C$K2_:+"XR8)\8/'56'8C(^OYXF,X3=D:XC!XK#1YY2NO)LR#XP\3?]##K' M_@;)_C33XQ\3?]#%K'_@;)_\56*:8:OE1RQK3_F?WFT?&/B?_H8M8_\``V3_ M`.*II\9>)_\`H8M9_P#`V3_XJL0TPU/*C>-6?=FV?&?BC_H8]9_\#9/_`(JF MGQGXH_Z&/6?_``-E_P#BJPS334M(WC4GW-L^-/%/_0R:S_X'2_\`Q5-/C7Q3 M_P!#)K7_`('2_P#Q581IAJ6D;QJ2[FZ?&OBG_H9=:_\``Z7_`.*II\;>*O\` MH9=:_P#`Z7_XJL$TTU+2-XSEW-[_`(3;Q5_T,NM_^!TO_P`533XW\5_]#-K? M_@=+_P#%5@FFFIL;QD^YO'QOXK_Z&;6__`Z7_P"*I/\`A-_%?_0S:W_X'2__ M`!58!IM2;1DSH/\`A-_%G_0S:W_X'R__`!5!\<>+/^AGUO\`\#Y?_BJQ+2VG MO+F.WM(9)IY&VI'&NYF/L*]V^&WPB@MHDU#Q;"LUT3F.RW9C08ZOZM[=![]D M:ILX#PG>_$/Q3>>1I&NZZZ*<23M?2B./_>;/Z=:^B/!FBWNA:>JZAK>IZI?L M/WLUQ=2.O7HJ,Q``XYZ_GBMR-%C14C4*BC`51@`>E.I%DGGS?\]9/^^C1Y\W M_/63_OHU'12&2>?-_P`]9/\`OHT>?-_SUD_[Z-1T4`2>?-_SUD_[Z-'GS?\` M/63_`+Z-1TV@"7[1-_SUD_[Z-)]HF_YZR?\`?1J,TTT"N2FYF'_+:3_OHTTW M,Y_Y;2?]]&HR*3%`KLD^TS_\]I/^^C1]IG_Y[2?]]&H\&DH"[)?M,_\`SVD_ M[Z-'VF?_`)[2?]]&HJ*!7)?M,_\`SVD_[Z-'VF?_`)[2?]]&HJ*`N2_:9_\` MGM)_WT:/M,__`#VD_P"^C45%,+DOVF?_`)[2?]]&C[3/_P`]I/\`OHU%BEQ0 M%R7[1/\`\]I/^^C1]HG_`.>TG_?1J/!HP:079)]HG_Y[2?\`?1H^T3_\]I/^ M^C4>#1B@-23[1/\`\]I/^^C1]HG_`.>TG_?1IFVC`IAJ/^T3_P#/:3_OHT?: M)_\`GM)_WT:9BEH`D$\_>:3_`+Z-'VB;_GM)_P!]&F4VD*Y+]HF_Y[2?]]&C M[1-_SVD_[Z-144!=DOVB;_GM)_WT:/M$W_/:3_OHU%10%V2_:)O^>TG_`'T: M/M$W_/:3_OHU%10%V2_:)O\`GM)_WT:/M$W_`#VD_P"^C45)3"[)?M$W_/:3 M_OHT?:)O^>TG_?1J*B@+LE^T3?\`/:3_`+Z-`N9O^>LG_?1J&B@+LL_:)O\` MGK)_WT:/M$W_`#UD_P"^C4"FG&@+DOVB;_GK)_WT:<)Y?^>LG_?1JN*<*!W9 M-Y\O_/63_OHTOGR_\]7_`.^C40I10%R3SY?^>K_]]&CSY?\`GJ__`'T:CHH" MY)Y\O_/5_P#OHT>?+_SU?_OHU'10%R3SY?\`GJ__`'T://E_YZO_`-]&HZ*` MN2>?+_SU?_OHT>?+_P`]7_[Z-1T4!?+_P`]7_[Z-'GR_P#/5_\`OHU'10%R3SY?^>K_`/?1H\^7_GJ__?1J.B@+ MDGGR_P#/5_\`OHT>?+_SU?\`[Z-1T4!K_]]&HZ*`N2>?+_`,]7_P"^C2>?+_SUD_[Z-,HI MCN/\^7_GK)_WT://E_YZR?\`?1J.B@=R3SY?^>LG_?1H\^7_`)ZR?]]&HZ*0 M7)//E_YZR?\`?1H\^7_GK)_WT:CHH"Y)Y\W_`#UD_P"^C2>?-_SUD_[Z-,I* M87)//F_YZR?]]&CSYO\`GK)_WT:CHH"Y)Y\W_/63_OHT>?-_SUD_[Z-1T4@N M2>?-_P`]9/\`OHT>?-_SUD_[Z-1T4#)//F_YZR?]]&CSYO\`GK)_WT:CHH`D M\^;_`)ZR?]]&CSYO^>LG_?1J.B@"3SYO^>LG_?1H\^;_`)ZR?]]&HZ*`'^?- M_P`]9/\`OHT>?-_SUD_[Z-1TE,+DOGS?\]9/^^C14=%`'S%XZ_Y'?Q!_V$+C M_P!&-6**VO'7_([^(/\`L(7'_HQJQ17HQV1\'B/XDO5BBG"FBG59S,?%&\TJ M1PHSR.P5449+$]`!W-=IING67@V^LKKQEI,]U-/$)X+/(4(-Q`,@/4\?=_/T M&]\!/#CW^O/K?_L[5C*=Y\AZ M=+".EA?KCWOHNGJ>W>&M3BUG0;'4;>$P17$8=8SC*CICBN*\._%:RUOQ+;Z/ M%IMS%+-(T8D9U(&`3_2N1\)?%RQT/PWI^F2Z9=2O;1",NKJ`W-<;\*I!+\3M M)D`P'FD;'U1JP5&W,Y(]B>:G>/;.;5;GQC<26NI/]AMK M6"P$)D59)26)957[^TO[XYH^-D'D?"W3HM0E,E[%+`H=SEGD"$,?Q&XUZS7S MI\?O$Z:KKT.D6D@:VT_/FE3PTQZC_@(&/J6J:;C.3=W+3\6_P MO^!Y0:8:>:::ZV?-1(S333S3#4,Z(C#3#3C334F\1AIAIYIAJ3HB,-,-/--- M2SHB,---/-/M+6>]NHK:TADFGD;:D<:Y9CZ`5#-XE>NM\$>`-9\67"F"%K:P MZM>3(0F/]G^\>.WXXKTSX>_!Z*W\K4/%86:7[R6*G*+_`+Y[GV''UKV2.-(H MUCC5411M55&`!Z`5#9U0IO=G->"_!&C^$K?&G0;[IAB2ZEYD?\>P]A73T44C M:U@%+24M(`HHHH`****`$-)2FD-`#310:0&@!:*1NE)FF(=0*;NI0PH`=12; MA1N%(0M%)N%&X4`+13=U&ZF`ZBF[J,F@!U%,YHH`?1D4RB@!V11D4VB@0^EI M!2T`(Q[4E)2T@"BBB@`HHHH`***2F`4444"$HI:*`"BBEH`2G@Y%-H7K0`IZ MTHI&H%`QXI:04M`"T444`%%)10`M%)10,6BC-%`!1110`4444`%%%%`!1110 M`4444@"BBB@`HHHH`2B@T4QA1112`****`"DI:2F`4444`%%%%(84444`%%% M%`!1110`4444`(:2E-)3`7-%%%`SYB\=?\COX@_["%Q_Z,:L05M>._\`D>/$ M'_80N/\`T8U8@KT8[(^$KK]Y+U8\4N::*7-4<[1]3_!^RCLOA[I7E@;IE:9S MZEF/],#\*\Q_:+_Y&?3?^O/_`-G:M?X(^.K.'3H_#VK3+!)&S&UED.$9222A M)Z'.<9ZYQZ9](\0^#]`\37$-UK%D+J5(]B.)I$^7.?X6`/6N*_LZCZ[X:\%:3%:2WD%K;VX\N.W5S)(/;;DM^)KYX\1^(]'741/X.TA M]*D1F(O'N)&F.002!N*KP3ZGT(JZ;E+F\SFQM.CA_9--)QM=+=[>7YV/8?BQ M\1H/#UI+IFCS)+K4@VL5Y%L#W/\`M>@_$]L_-LC,[,SL69CDDG))I9'9W9G8 MLS')).233#6L(*"LCS<5BYXN?-+;HAIIAIQIIIF44,---.-,-2S>(PTTTXTP MU+.B(PTTTXTPU+.B(TTTTXUZ/\,_AK=:_<0ZAK$+P:,"3M8E7GXXV^BYQS^5 M0W8Z:<7)V1R?A?P?K?B=F_LBR:2%6`>=V"1K^)Z_09-?0OP\^'UAX/C,^\W6 MJ2)MDN&&`H[JH[#CZFNOLK2WL;6.VLX(X+>,;4CC4*JCZ"IQ63E<]&G14->H MM)2TE2:A1113$+1112`****`"BBB@!#2&E-)0`TTWH:<:::`%ZBFGBE4\TM, M0VBE(Q24A!1110`4444`%%%%,!11112$%%%%`!1110`444HZTP'BD;I2TC=* M`$HHHI`%%%%`!1110`E%%%,044E+0`444M`!1110`4=Z*0T`.;I2"E/W::*` M)`:4&F`THH&/S2&DS24"'4F:2B@8N:7--HH`?FBF@TH-`QV:*2E%`!1110`4 M444`%%%%`!1110`4444@"BBB@!#12FDIC"BBB@`HHHI`%)2T&@!****8!111 M2&%%%%`!1110`4444`%%%%`"4E+24P"BBB@#YA\=G_BN/$/_`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`_&%KJ^ESV=P;=H1_9&YA)&&@YHK9Z5`99>K,>%C7U8]A7T;X"\":=X2M]Z M`7&I.N);EAS[A1V'\^]9RE8[J%"53T.4\!_"*'39UO?$KPWDZ',=M'DQ*?5B M0-Q]NGUKUH````8`["BBL6[GJPIQ@K1"E%)2BD4+24M)0`44E**8A:***0!1 M110`4444`%)2T4`--,(I](:`(R*4'UI332*8A])MI%/K3Z`8S::,>4A$># M1BI**`(\&EP:?13`9@TN#3J*`&X-J*`&X-Y%)NH`-M*!BDR:`:!#Z1 MNE+0>E(!M%)2T`%%%%`!1124P"BBDH$+112T`%%%%`!1110`4=Z*510`/]VF M"ED--H&/'-.Z"@<"HW;-`A2_I2%R:;10`9-.#$4VEQ0!(&!I:BQ3U/8T#'4` MT4AX-`#P:6F`TX4#'"BDI:`"BBB@`HHHH`****`"BBBD`4444`%)2TE,8444 M4`%%%%(`HHHH`2BBBF`4444`%%%%(84444`%%%%`!1110`4E+24P$HHHH`^7 M?'A_XKCQ#_V$;C_T8U=5\1-=#:+X.BTK5`3#I,4S1I]=EKI_5DOT/=/!=QH-KHOAV70]0\-V5PDB/JKZFRK=$@J6$98< M#[V.G;D'-5=,UO2QXL^(D[:C9K#=VDBV[M,H$QVGA"3\Q^E>+9I,T>S\P6-: M44HK3_*QZAYUCKOP:L=/CU2PM;_1YIKB6"YEV/*O[Q@(Q_$3O4`>O>L[XG:A M:7FC>#([.[@N&M])BCE6*0.8W"KE6`/!XZ&N`S2$TU&SN9RQ#E#EMT2^[8]1 M^*^J6%]X^\.W-E?6MQ!':6RR2Q2JZHPE!?` MVH^+;@F(FUL$R'NG3<,^BCCX^GHOO^5? M0-E:P6-I%;6<*0V\2[4C08"BLYSMHCOPV$<_>GL9_AKP_IWAS35LM+@$YK6HHK`]9))604444`%+24M`"TE+24`)2BDI13$+1112`****`"BB MB@`HHHH`0TE.I#0`TBFD4\TAIB(R*53BEQ2$4@'TTM0I[4$>E`@W>U&[VIM% M,!V[VHW>U-HH`=DT9-)12$'-%%%`!1113`*6DI:`'+TI:1>M+2`;T-%*P[TE M`!1110`4E+24P"BBDH$+2TE+0`4444`%%%`&:``#/TIU%-G_BNO M$7_81N/_`$8U80-;?CX_\5UXB_["-Q_Z,:L+-=D7H?*58^^_4?FES4>:7-5< MQY1^:,TS-&:+ARCLTF:;FD)HN-1'$TTFD)I":5RU$4FF$T$TTFE[?YX+>1 M<"(9X9@>I/4>G'?IZW6$ZG1'KX7!JW/4^X9;PQV\$<$"+'#&H1$48"J!@`>V M*?116)Z84444""BBB@`I124HH`6DI:0T`)2BDI13$+1112`****`"BBB@`HH MHH`****`$-)3J0TQ#<4A%.I"*`&$4H-*1332`<1FFE:56[&G4Q$=%24F!0`V MBG;11@4"&T4[`I<"@!E%/HH&-P:4`TN:3=0(4#FEIN31DT`.II@YI3S2` M;10>**`"DI:2F`E+124"%HHIRB@!`":7;2T4`(`!2T4TMCI0`K'%1G)H)S10 M,3%2KT%1U*.E`B.0!312YH`#244JC)H&!%(>E M*W6FN<"@!HIPI@IPH&/%.I@I:7-.YERC\T9IF:,T7%RCLT9IN:3-%RE$7-)FD)H4%F" MJ"6)P`.II7*422V@FNKB."VC>6:1@B(@R6)Z`"O=_!'PJL+/3A+XDB^TW\HR M8UE95B'IE2,GU/3^=6?A#X'_`+"L/[2U:V4:M-]P-R8(R!QCLQYS[8'K7I%8 M3J.^AZ^&P4>7FJJ]^AR?_"N_"W_0+_\`)B7_`.*H_P"%=^%O^@7_`.3$O_Q5 M=914^TEW.CZEA_\`GW'[DTEW#ZEA_^?%O\`H%_^3$O_`,51_P`*[\+?]`O_ M`,F)?_BJZVDH]I+N'U+#_P#/N/W(Y+_A7?A;_H%_^3$O_P`51_PKOPM_T"__ M`"8E_P#BJZRE%/VDNXOJ>'_Y]Q^Y')_\*Z\+?]`O_P`F)?\`XJC_`(5UX6_Z M!?\`Y,2__%5UM%+VDNX?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*/:2[A]3P__/N/W(Y+_A77A;_H%_\`DQ+_`/%4?\*Z\+?] M`O\`\F)?_BJZVBCVDNX?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*/:2[A]3P__/N/W(Y+_A77A;_H%_\`DQ+_`/%4?\*Z\+?] M`O\`\F)?_BJZVBCVD^X?4\/_`,^X_%O^@7_Y,2__`!5'_"NO"W_0 M+_\`)B7_`.*KK:*?M)=Q?4\/_P`^X_'_Y]Q^Y'(GX=^%O^@7_`.3$O_Q5-/P[\+_] M`O\`\F)?_BJZ\TA%'M)=P^IX?_GW'[D<@?AYX7_Z!G_DQ+_\52?\*]\,?]`S M_P`F)?\`XJNN(II%'M)=P^IX?_GW'[D>%O^@9_Y,2__ M`!5'_"O?"W_0+_\`)B7_`.*KJJ*7M)=P^IX?_GW'[DTEW%]3P_P#S[C]R.4_X5YX7_P"@9_Y, M2_\`Q5*/AYX7_P"@7_Y,2_\`Q5=52T_:2[A]3P__`#[7W(Y3_A7GA?\`Z!?_ M`),2_P#Q5'_"O/"__0+_`/)B7_XJNLHI>TEW#ZGA_P#GVON1R?\`PKSPO_T" M_P#R8E_^*I1\//"Q_P"87_Y,2_\`Q5=72K1[27'_`.?:^Y'*?\*[\+?] M`O\`\F)?_BJ0_#OPO_T"_P#R8E_^*KK:0G%'M)=P^IX?_GVON1R7_"O/"_\` MT"__`"8E_P#BJ/\`A7GA?_H%_P#DQ+_\576'FDI^TEW#ZGA_^?:^Y')_\*\\ M+_\`0,_\F)?_`(JC_A7GA?\`Z!G_`),2_P#Q5=924>TEW%]3P_\`S[7W(Y4? M#SPO_P!`O_R8E_\`BJ=_PKOPM_T"_P#R8E_^*KJ:?1[27'_Y]K[D'_Y]K[D'_`.?:^Y') M_P#"O/"__0+_`/)B7_XJC_A7GA?_`*!?_DQ+_P#%5UM%'M)=P^IX?_GVON1R M:_#SPN3_`,@O_P`F)?\`XJG?\*[\+?\`0+_\F)?_`(JNL'2D)`-'M)=P^IX? M_GVON1RG_"N_"W_0+_\`)B7_`.*J,_#WPP#_`,@S_P`F)?\`XJNPI&7-'M)= MQ?4\/_S[7W(Y`?#WPO\`]`S_`,F)?_BJ>/AYX6[Z7_Y,2_\`Q5=1@@\TX4>T MEW#ZGA_^?:^Y'+?\*[\+?]`O_P`F)?\`XJC_`(5WX6_Z!?\`Y,2__%5U8IPH M]I+N'U/#_P#/M?M+VDNX?4\/\`\^X_'_Y]Q^Y'*_\*[\+?]`O_P`F)?\`XJD_X5YX5_Z! M?_DQ+_\`%5U=%'M)=Q?4\/\`\^U]R.4_X5YX5_Z!?_DQ+_\`%4?\*\\+?]`O M_P`F)?\`XJNJI*/:2[C^IX?_`)]Q^Y'+?\*[\+?]`O\`\F)?_BJ/^%>>%O\` MH%_^3$O_`,5759IU/GEW#ZGA_P#GW'[D'_P"?%?^@7_P"3$O\` M\51_PKKPK_T"_P#R8E_^*KK:*7M)=P^IX?\`Y]Q^Y')?\*Z\*_\`0+_\F)?_ M`(JC_A77A7_H%_\`DQ+_`/%5UM%'M)=P^IX?_GW'[D%O^@7_Y,2__`!5=;13]I+N'U/#_`//N/W(Y+_A77A;_`*!?_DQ+ M_P#%4?\`"NO"W_0+_P#)B7_XJNMHI>TEW#ZGA_\`GW'[D%O^@7_P"3 M$O\`\51_PKKPM_T"_P#R8E_^*KK:*/:2[A]3P_\`S[C]R.2_X5UX6_Z!?_DQ M+_\`%4?\*Z\+?]`O_P`F)?\`XJNMHH]I+N'U/#_\^X_%O^@7_P"3 M$O\`\51_PKKPM_T"_P#R8E_^*KK:*/:2[A]3P_\`S[C]R.2_X5UX6_Z!?_DQ M+_\`%4G_``KOPM_T"_\`R8E_^*KKJ2CVDNX?4\/_`,^X_UC>6>5@J(@R6)[`5]%_#?X>VGAVSCNM3ABN= M7?#%F4,(/9/?U;^E4?@[X&DT&U;5=7A4:C<*/*C8?-`G?Z,<\^F,>M>FUC.= M]$>KA<*HKGGN%%%%9G>%%%%`!1110(****!!1110`4M)2T`+2444`%%%%,0M M%%%(`HHHH`****`"BBB@`HHHH`****8@I:2EH`0TE.I,4@&D4TBGTA%`$9%) M4A%-(I@*IS013>AIP.:!"8-)3Z*`&44[`HP*!#:!3\44#$P:7;2T9H$&!12; MJ4*`"F._84C-G@=*90, M*4M8'P3\#7%M=-KNM6IB*KMM89 MD(8'/,F#TXX'U)]*]HK.WOR"BBBLSN"BBB@`HHHH`****!!1110( M****`"BBB@!:*!10`444E,0ZBDI:0!1110`4444`%%%%`!1110`4444Q!2BD MH%`"T444@"DI:*`&D4TBGTA%,!F*0T_%)BD`S)%+N]:"*0B@0[<*6HL5*.E, M`I"WI2'K24`+2TE+0(*5>E)2KTI`#=*2E;I24`%%%%`!24M)3`*!P:**!#P< MT$9IE*&H`7%�"#2T``I&.!2GBH^IH`44X4@IPH`44X4@IPH`6F.)O^PG<_\`HUJY[-:IGGRCJQ^:,TS-+FBY/*.S7LGP M9^'YN7A\0:U$/LZ_-:0./OGM(1Z>GKU^O,_";P1/XDUBWO;ZT9M"A<^:[-M$ MC`<(.YYQG';/.:^F418T5(U"HHP%48`'I4RET1T4*-WS2%I:2E%9':%%%%,` MHHHH`****`"BBB@04444""BBB@`HHHH`44M(*6@!*2EI*8A:6D%+2`****`" MBBB@`HHHH`****`"BBBF(*!110`M%%%(`HHHH`*2EHI@-Q1BEQ10`PBD(IY% M(12$1XYI])CFEI@-/4TE*>II*!!2TE+0`M*O6DH[T@'4VG4T\&@`HHHH`*** M*`$HI:2F`E%+10(2GK30,FGDX%`#'/.*!2=3FG"@!13A2"G"@!12]!0*1CVH M&-)S244US@8H`8QR:!0*44#"EI:!UH`=2-VI:1NU(0E%%%`!1110`4AHH-,! M****`"BBBD`4444`%%%!H`<#D4AX-(IYIQ&13&`-.%1BG@TACZ6FBE%`"TE+ M24P"BBB@`HHHI#"BBB@`HHHH`****`"BBB@!#24II*8"T444#/D#XBG_`(N! MXF_["=S_`.C6KGLUT'Q&/_%P?$W_`&$[G_T:U<[FK1R26H_-=3\//"-UXOUQ M+:,.EE$0US.!]Q?0?[1[?GVK#T#2KK7=9M-,L5!N+F0(I.<+ZL<=@,D^PKZT M\&>&;+PKH<6GV*@L/FFE(^:5^['^@["DW8<*?,]33TK3[72=.@L;")8;6!=B M(.P_Q]ZM&BBH.M:"4444BA:***8@HHHH`****`"BBB@04444""BBB@`HHHH` M6EIM+0`4E+13`!2TVG4""BBBD`4444`%%%%`!1110`4444""BBBF`HHI!2T@ M"BBB@`HHHI@%%%%`"&D-.III"&]Z***8#3UI*5J2D(*6DHI@+2TE%`#EZ4I& M130<&G4`-HI2,TE(`HHHH`****`"DI:`,FF`JCBFLIR*92@X-`"MU MS0*4\BFBD,D%+3`:>*`%HI.]+3`****`"BBBD,****`"BBB@`HHHH`***2@` MHI*6F`4444#/CWXC'_BX/B;_`+"=S_Z-:N>4%F"H"S$X`'))K?\`B/\`\E"\ M3_\`83N?_1K5ZC\%/AS_`,>OB76U_P!NTM67Z;96_7`QZ&G#0`E%%%`@I1244`.I5--HI`/I"/2@-ZTM`#:*<1FDQ0`E%%)0`4 M\#`I`.](YQP.M,!"E(PYS2*<&G$9%(!!3J8*<#0,=2T@I13` M6BBB@`HHHI#"BBB@`HHHH`****`"DI:2@!*6DI:8PS12T4@/F(^$I_&'QD\1 MV:;DLX]3N9+F8?P)YK<#W/0?GVKZ:151%5%"JHP`!@`50TS0K+1;O5'LD/F7 MUY+=SR/@LSNQ.,@=!G`':M"@:5@HHHH&%%%%`"&BE-)2`444"BF`4444`%%% M%`!1110`4444""BBB@04444`%**2EH`6D-+24`)2T4E,0ZBBBD`4444`%%%% M`!1110`4444`%%%%,04444`+1112`****`"BBBF`AI#2TTT`(:0=:4TF*0A: M",T4F:8!M%&!110`8%&T444`)BCI2YI:`&TH.*,4E`AX.:*;0#2`=1B@'-%` M`3@5'U.:5SGB@4P%%.%(!3A0`"G"@4$XH&(YYQ3:*1C2$(>M%%%`!1110`44 M44`%)2T4`%%%)0`444E,`HHHH`****0!1110`4444`%)113&%%%.4=Z`&T4K M=:2D`4]3D4RE4X-``W!H!I6Y%-!IC)!2TT4X4`.HI!2TAA1110`4444`%%%% M`!1110`4E%)3`6BBEH&%%%%(!]S_`,?,O^^?YU%4MS_Q\R_[Y_G45!3"BBB@ M`HHHH`*2EI*`"EI*6@`HHHH`****`"BBB@`HHHH$%%%%`@HHHH`****`%I:2 MEH`2DI:*8`*6DI:!!1112`****`"BBB@`HHHH`****`"BBBF(*6DI:`"BBBD M`4&BDH`0TAH-)3`**0T4""BEHH$)11UH-`PHHQ10`8I*6B@`H(!HHH`3I2T= M12=*!"CK2L<"A>F:83DT``IPI!3A2`44X4@IPI@'2FGFE;TIM`!3:5J2D`44 M44`%%%%`!1124`+2444P"DHHH`***4CTH`2BBBD`4444`%%%%`!1124P"BBC MK0,4#)I](!BEI`,;K24K=:2@`HHHH`<.133P:53VI6'%,8"G"HQ3Q0`ZG4T4 MHI#%HHHH`****`"BBB@`HHI*`"DHI:8!2TE+2&%%)10!)<_\?,O^^?YU%4MU M_P`?,O\`OG^=14%,****`"BBB@`I*6B@!*44E%(8M%%%,04444`%%%%`!111 M0(****!!1110`4444`+124HH`**6DI@)2TE**!"T444@"BBB@`HHHH`****` M"BBB@`HHHIB"BBB@!:*04M(`---+2&@!IHHHH$)BBEHI@)2FBCO0`"BBB@!! M2T4E`A:3%+12`2BEI*8P[TM)2GB@!KGBFBCJ:44"'"G"FBG"@!PI#FBF9YI],844$XINZ@!U%-W4XD(****`"BB@T`%1R$AN*DIDHXS3`52&%)TJ-3@Y MJ4\C(H`2BDI:0@I5'>DI6.!3`1CDXH%(*<*`%%.%(*<*!BBFLE)2$.!I:913`?13**!C\TF13:*`'9%&: M;10(?36[4X=*1NE`QM%)10`5(.E1T\=!0`C=:;3GIM`!3E/--H'6D!)4=24Q MNM`"4444`.7I0>E(.M.IC&4E*>#24A!2T44#`<&G'D4VE4T`(*<*:PP:44#' MBG"F"G4`.HI*6@`I#2TE`"4M)2TQA12TAI`)1110`4444`27/_'S+_OG^=1U M)<_\?,O^^?YU'2+"BBBF(****`"BBB@`I*6B@!*6DHI`+1113`****`"BBB@ M`HHHH`****!!1110(****`"EI**`'4E%+0`E)2TE,!:6DI:0@HHHH`****`" MBBB@`HHHH`****`"D-+2&F(::::<:::`%H[T44`+1112$%%%%`"=Z&&012T4 M`5SQ4D;=J20O2E/2F+UI]`$=%*PYI*`"GKTIE.7I2`5N13*DJ.@`HH MHH`>O2D>A32GF@!E%%%`!3J;2J:!@PI*?3*`"BBB@`I`<&BB@!Y&1313E.13 M6�,<*<*8*<*`'BEIM+0`4E+13`*6DI:0PIM+24`%%%%`!1110!)<_\?,O^ M^?YU'4EU_P`?,O\`OG^=1T%A1112`****8@HHHH`****`$HI:2D,6BD%+3$% M%%%`!1110`4444`%%%%`@HHHH$%%%%`!1110`M+3:44`%%+24P$I:*2@0ZBD MI:0!1110`4444`%%%%`!1110`4AI:0T`(:8:>:::!"#I2TT=:=3`!2TE+0`4 M444A!1110`A&1BH6&#BIZ:R[J`&1'G%2U&J$-3G/%`#"*=0W2@! MM)110`4444`%%%%``.M25&.M24`(PR*94E,88-(!*>13*M,!M*IQ2'`[T4`244U>E.H`3%&*6B@!,4&@FB@ M`H'(HH%`#** MM/H`81BDJ0TS!H`53Q2TU13J8QI%)3CTIM(04H/-)24`24PC!IPY%#"@8VBB MB@`!P:?4=.4\4#$81D4R@`HHHH$%`X-%%`#^HIO0T*>U#>M`Q0:<*8* M<*8QXIU-%+2`*2BB@`HHHH`****`"BBB@"2Z_P"/F7_?/\ZBJ6Z_X^9?]\_S MJ*@L*6DI:`"BBB@04444`%%%%`!1110`E%*:2D,6BDI:8@HHHH`****`"BBB M@`HHHH$%%%%`@HHHH`****`"EI**`'4E%+0`E)2T4P"EI**!"T444@"BBB@` MHI*2@!*2GD9%,H`*`<&BB@"2FL.]*O2EH&1T4K#!I*!!11 M10`4[J*;0.M`PZ&G"@BD!IC)`:*:#2BD`ZBD%+0`4444`%%%%`!1110!)=?\ M?,O^^?YU%4MU_P`?,O\`OG^=14%A2TE%`"T444@"BBBF(****`"BBB@`I*6B M@!*44E%(8M%%%,04444`%%%%`!1110`4444""BBB@04444`%%%%`"T"DI:`% MI**6@!***2F`M+244"%I*6DI`)2$T&DH`***6@`Q1110`M&*2EH`,4VG4C=* M!"4444`+12"EH`****8!1110`AHI:2@`S2TE+0`GX48'I2T4A"8'I1Q2T4`) M1S2T4`%&***`"@T44`)10:*``4,<"@5&[9.!0`A.>M%%+0,3%+BEQ2XI@)BC M%.Q2@4`-Q2XI<4N*`&XHQ3\4F*`&8I"*DQ32*`&8I.1TIY%(12&`;UIP.:9B MD^E`$M)30V.M.!!H$(1Z4+FG44#"FL,TZB@".BG,/2FT"%!P:?4=.4]J!BD9 MIAE(>10`RBBB@`HHHH`4&@\4E.ZB@8@-.!IG2E!H&2"E%,!IU`A:*!10` M4444`%%%%`R2Z_X^9?\`?/\`.HJENO\`CYE_WS_.HJ"@HHHH`6BDI:0!1113 M$%%%%`!1110`4444`)12TE(!:*2EI@%%%%`!1110`4444`%%%%`@HHHH`*** M*!!1110`4444`+2TVEH`**6DH`*2EI#3$&:#24F:`"@44H%(!11110`4444` M%%%%`!112$T`)1110(*4=*2@'%`#L4E+10`E%+BDH`****8"4"@T4`+1110` M4444@"BBB@!**6DI@%%%)0`4M%(3B@!'/:F4=:4"@8`4X"@"G`4"$`I<4HI: M`$Q2XI:,4`)2TM%`"8HQ2T4AC:,4ZDQ0`W%)BG48H`9BFXJ0BD(H`C(I,5(1 M3<4`-R12[C1BC%`!O-.#`TS%)0,FI",TQ6QUI]`AI4TH%.I*`"DHHI@!%-/% M.HH`;101BBD`4#BBB@!W6DQ2`\TXT#`4X5'FGB@!U+313A0`4444#"BBB@9) M=?\`'S+_`+Y_G452W7_'S+_OG^=14#"BBB@`HHHH`6BBBD`4444Q!1110`44 M44`%)2T4`)2TE%(8M%%%,04444`%%%%`!1110`4444""BBB@04444`%%%%`! M1110`M+3:6@`I#2FD-`#33:4TE,0Y:=2#I2B@`HHHI`%%%%`!2$T,>*2@`HH MHH`***2@!:*0$&EH`4&EIM.'2@04444`)12TE`PI*6@T`(*6DH%`A:*3-&:` M%HI.:*`#-%%%`!12$@=33"_I3`M`"!<4C'G%!;TIHH`<*<*:*<*!CA3A313A0`4444#"BBB@" M2Z_X^9?]\_SJ*I;K_CYE_P!\_P`ZBH&%%%%`!1110`4M)2B@`HHHI`%%%%,0 M4444`%%%%``:2EI*0!2TE%`"T444P"BBB@`HHHH`****`"BBB@04444""BBB M@`HHHH`***#0`4A-!IIH`#2KUIM/7I3`**6C%`"4M&**!!112-TI`)UHHIKM M@>]``S`4SS#FF$YZTJ#+4`3#I37/:G$X%1]3S0`"I`O2F5(O2@`HHI:`$HI<48H`2 MFMUI]1MUIB#-0LO2@0M+244`+2TVEH`*C/6I:C<U)1WH8X&:`$9@M*#D5"3DU M+']P4`.I5[TE*M`"T444`%(:6B@!*0TM(>E`"'I4535%WH`<*<*:M/%`"BEQ M0*44`)2XI:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**3-& M:`"BDI:8"44M%`!12T4AA1244`%%)10`4444`%%%%`!1110`48HHH`,48HHH M&%%%%`PHHHH`****`"BBB@`HHHH`DNO^/F7_`'S_`#J*I;K_`(^9?]\_SJ*@ M84444`%%%%`!1110`4444`+124M(`HHHH`****8@HHHH`****`"DI:*`$HHH MI#%HI*6F(****`"BBB@`HHHH`****`"BBB@0&D-*:0T"&FD%*::*!BT]*93E MZT"'4444`%%%%`"TUN12T4`1T4I'I3`:QR?:@4@IPI"%%+124P"HY6R<4 M]C@5#U-`!4T?W!40&3BIAP,4#'4X<"F@9IU(04444`%%%%``::>E.I&H`2H^ MYJ2H^YH`44\4Q:>*`'"G4T4Z@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI M*,T`+244E,!:*2EH`2BEHH&%%%+0`E+124@"BBDH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH&%%%%`PHHHH`****`"BBB@`HHHH`**,T4`277_'S-_OG^=15 M+=?\?,W^^?YU%2&%%%%,`HHHH`****`"BBB@`HHHH`6BDI:0!1113$%%%%`! M1110`4444`%)2T4`)1112&+124M,04444`%%%%`!1110`4444`!I#12&@0TT M@ZTIIN>:`'4HZTE%`B2BD7I3L4#$HI<44`)13J2@!K#C-,/2I<5&PP:!#!3A M1THH`6DHHI@1R')IH&:DV#/-.`QTI`(JX^M.`S2A?6GXP.*8"`8%!HHI`)12 MTE,04M)10`M,SS2GI3:`%-1]Z,4P4`.%.%-% M/%`#A3A312T`.%+24E`#J*2B@!:2BB@`HI**`%HI**`%S1244`+2444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110,****`"BBB@84444`%%%%` M!1110`4444`%%%%`!2444AA2T44Q!1110`4444`/NO\`CYF_WS_.HJENO^/F M;_?/\ZBI%!1110`M%)2T`%%%%,04444`%%%%`!1110`4444`%+244`+1112` M****8@HHHH`****`"BBB@`I*6B@!#29HIII#`FDHHIB%`R:D'%-08IU`!111 M0`4HI*44`%%+10!"1@XI*?)UIE`A5.#4U05)&A[4CCG--H`DHINXT;CZ4`.HIFXT9-`#\BD+>E,HH`4G-)110`4C'`H9L M"H^IR:`#J:4"@4X4#%`IPI`*<*!"BE%(*6@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH&%%%%`!1110,**** M`"BBB@`HHHH`****`"BBB@`HHI*`"BBBD,*6BBF(****`"BBB@`HHHH`?=?\ M?,W^^?YU%4MU_P`?,W^^?YU%2*"BBB@`I:2B@!:***!!1113`****`"BBB@` MHHHH`****`"EI**`%HHHI`%%%%,04444`%%%%`!0:*2@!#332FFT`%*!DTE/ M7I0`M+244@%HI*6F`4ZFTO:@!::7`ICMG@=*;0`I.3FDHHH`*53@TE%`B>BF MH>M1-]Z@0N M\TF2:2E%`"8I<4H%.Q0`W%+BG8I<4`(!2@4N*7%``!2T4M``****!!1110`4 M444`%%%%`!1110`4444`%%%%`!1110,****`"BBB@`HHHH`****!A1110`44 M44`%%%%`!1110`4444`%%%%`!1110`444E`"TE%%(844M%`@HHHI@%%%%`!1 M110`4444`%%%%`!1111<+#[K_CYF_P!\_P`ZBJ6Z_P"/F;_?/\ZBI%!1110` M4444`%%%%`!2TE%`"T444Q!1110`4444`%%%%`!1110`4444`%+244`+1112 M`****8A*::=330`TT444`*O6GTQ>M/H`6B@44`%%%%`#7Z4RGOVIE`$<4VE7[PH`FHHHH`****`$- M)2TE`$;?>-1OU%2-]ZF-TH$-%.%(*<*!@!3@*`*=0`F*7%%+0`48I:*`"BBB M@`HHHH$%%%%`!1110`4444`%%%%`!1110`4444`%%%%`PHHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHI*`%-)112&%%%+0(2EHHI@%%% M%`!1110`4444`%%%%`!1110`4444AA1110`^Z_X^9O\`?/\`.HJENO\`CYF_ MWS_.HJ!A1110`4444`%%%%`!1110`M%)2T`%%%%,04444`%%%%`!1110`444 M4`%%%%`!1110`M%)2T`)333J::0#:*.]%,0J]:?3!UI]`!2TE**`"BBB@!'Z M5'4IZ5%0`4PG)IS'`IHH$*!3J04M`!29&<4CM@<=:;$.]`R2G)]ZFU(@P,T` M/HI*,T`+24E%`!1110!&WWC36Z4X]::>E`#13Q3!3Q0`X4ZD%**`%Q1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1124`+2444AA112T`)2T44Q!1110`4 M444`%%%%`!1110`4444`%%%%`!1112&%)113`****`)+K_CYF_WS_.HJENO^ M/F;_`'S_`#J*D,****`"BBB@`HHHH`****`"BBB@`I:2B@!:***8@HHHH`** M**`"BBB@`HHHH`****`"BBB@!*0TM--`"&B@T4@"GCI3**:*<*`'BE%(*<*`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBDH`6BDHI`%%%%`PHI:*!"4M%%,`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHI#"BBDI@%%%%`!1110`4444`277_'S-_OG^=15+=?\`'S-_ MOG^=14AA1110`4444`%%%%`!1110`4444`%%%%`!2TE%`"T444""BBBF`444 M4`%%%%`!1110`444E`!332FFF@!IIU)BEH`*4'!I**0$E%(IR*6@`HHI:8@H MI*6@"-A@TE/<<9IE`!3@II4%.H`0*!2T44`%%%%`!1110`4E+10`AX%1TYCF MFT`(QP*C%*QR:`*0"BGBFBGB@8X4HIM.H$+1244P%HI*6@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI**+@+1244@%I***!A1110`4 M4M%`A**6BF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%(`HHHH&% M)113`****`"BBB@`HHHH`**B^T0_\]H_^^A14\\>Y7)+L6;K_CYF_P!\_P`Z MBJ6Z_P"/F;_?/\ZBIB"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`I:2B M@!:***`"BBBF(****`"BBD-`!2&@TAH`0T44X"@``H(I:*`&44K"DH`53@T^ MHZ>IH`6BBBD`4444""F,,>C#BF`B=<4^HQQS4F:`"BC-&:`"BBC-`!11FD MS0`M,8YXH9L]*;0`4USQBG$XJ/J!0``4X"@4X4`)2THHH`2BEH MH`2BEHI`)12XI*!A11BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HI:*!" M44M%`"44M%,`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH&%%%%(`HI**8!1110`4444`%%%%`!1110`5D>*+_`.PZ6X4XFF^1/ZG\ MJUZ\Z\37YOM4DP3G.,^JX9\OQ2T7ZL]+*L+]8KJ^T=69^T M>E%+17P=D?97/6+K_CYF_P!\_P`ZBJ6Z_P"/F;_?/\ZBK]1/SP****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`I:2B@!:*2EH`****8@I*#2&@!#2 M44"@!0*=112`****8!3*?33UH`2BBB@!X-+3%]*=0`M%&:*0!1110`P\&E4] MJ'IM`B2BF[C1NI@.HINXTE`#BPII.:2B@`H)Q2%@*8230`$Y-**0"G`4`*!3 M@*0"G@4``I112T`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%(84444`%%)13`****`"BBB@`HHHH`****`"BBB@`HHJO?WD-C M;-/<-M0<#U)]!4SG&$7*3LD.,7-J,5=LR_%6I_8;+R8FQ<3#`Q_"OK'@?W1V%5L5^=YICGC:[FOA6B]/^"?Y-11BBN0Z3 MUBZ_X^9O]\_SJ*I;K_CYF_WS_.HJ_4#\]"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@!:*2@T`%--*:::!!2BDI1TI@**6FTN:0"T M444`(>E-I3S3)-<#))9V1.<[9)!TQZ"N6"U\AGN9*M_LU)Z+=_H?3Y/@'2_?U%KT7ZD M>VC;4H6G;:^;Y3WN8-M%3;316W*8\QZ==?\`'S-_OG^=15+=?\?,W^^?YU%7 MZ8?`A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4A MI:2@!#3:4T@H`6E'2FTX=*!!1110`HI&-%!ZT`-)P":9&,G)IY&1BD8X&!3` M1CV%.7I3!3UZ4"%I5I*5>M`QU%%%`!1110`4RGTR@".0IKYS-\U2BZ%!Z]7V\CW@!:44E`ZTQ#J*2EI`%(>M+2&@`J,\FGL<"F"F(4"GT@%+0` M4JT@&:?0,****`"BBB@!#3:5C24`,?J*04/UH%`#A3A2"G"@!12T4M`"8I<4 M44`%%%%`!2TE%`"T4E%`"T4E+2`****`"BC-%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%&:`"BBB@`HI**8"T4E%%@%HI**`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHIDLB0QM)*P1%& M22>!2;25V"3>B'USOB36##_HMFX\PY$C#^'V'O5+5?$*Q&R(\>8?O'Z> ME8:#/)ZU\QF>$K50,W,BV459V45KR&7.===?\`'S-_OG^= M15+=?\?,W^^?YU%7W!\B%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!332FD-`#33>].--QDT`.HHHIB%HI!2T`+2&BB@!K=*1:<: M*0"T#FBEH`7-+3:*`'44F:,T`+1132>U``>M)136.!3`8>M.%-%/%`#A3A2" ME%`#A1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`+2444`+2444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445SNN>(XK96AL M6$EQTWCE4_Q-WJ?8"N) MUG69=38(!Y=NIRJ=R?4UG75W/>R^9=2M(_3)[?0=J:@KX_,,XJ8O]W#W8?B_ M7_(^HP65PPOOSUE^"]!Z"IT6F(*L1K7F01WR8Y%J=%IJ+5B-:ZH1,)2!%J=5 MI46ID2NF,#"4ABI3PE3*E2!*V4#%S(=M%6=GM16W(9\YN77_`!\S?[Y_G452 MW7_'S-_OG^=15]8?-!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!2&EIM`!2&@TE`!BBEHH$)12TE,`I:2@4`+1110`AHI:2@!12TE%`"T M4E+2`**,TF:`%)I***8!4;')H8YI!0`HIXI!3A0`HIU(*44`+1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4455OK^VL4W7,RIZ#N?H*B=2-./--V14(2F^6*NRU5 M74+^WL(#)<2!>.%[M[`5Q^J>)[JYREH/L\7J#\Y_'M^%8,TLDSEYI'D<_P`3 ML2:^[ALCG*TJSLNW4U]8\075_NC0^3;G^!3R?J:QU MIM.6OE*V(J8B?/5E=GTE*C3H1Y*:LB1!4Z#FHDJ>,41029*@JQ&*BC%6(Q75 M!'/)DT8JQ&*BC%6HQ77!'--CT6K"+3(Q5E%KKA$YI2!5J4)3D6I56NB,3!R( MMM%6-M%;>>(O^0W<_6BBOG^(OX$?7]&>WD?\`&EZ?J9U% M%%?'GTX4Y:**:!DRU+'VHHK:!C(L)5F*BBNF!SR+"59CHHKL@ GRAPHIC 5 g31893ex99_1s12gbgd.jpg GRAPHIC begin 644 g31893ex99_1s12gbgd.jpg M_]C_X``02D9)1@`!`0```0`!``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`+1`\(#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#WJ_O+E;VX M5;B8*)&``<\Q9.H7G_`#]W'_?P_P"--.HWG_/W M6J,/Y5]Q=.L:E_T$;S_`+_M_C33 MK&I_]!&\_P"_[?XU2-,-0Z]3^9_>4J-/^5?<73K.I_\`01O/^_[?XTAUG4_^ M@E>_]_V_QJB:::EUZO\`,_O*5&G_`"K[B\=9U3_H)7O_`'_;_&FG6M4_Z"5[ M_P!_V_QJB:::AUZO\S^\I4:?\J^XO_VUJG_02O?^_P"_^-)_;6J_]!.]_P"_ M[_XU0-,-3[>K_,_O97L:?\J^XT#K>J_]!.^_\"'_`,:3^V]5_P"@G??^!#_X MUGTA-'MZO\S^]A[&G_*ON-'^V]5_Z"=]_P"!#_XTTZYJH_YB=]_X$/\`XUFE MJC9J:KU?YG][$Z5/^5?<:;:[JW_04OO_``(?_&HVU_5O^@I?_P#@0_\`C68[ MXJL\E6JM7^9_>R73I_RK[C7?Q#JX_P"8K?\`_@0_^-5W\2:P/^8MJ'_@2_\` MC67&LMS.D%M&\LSG"H@R2?I7H/ACX>#Y+G7SD]1:HW`_WB/Y#\Z]#"8?$XF5 MJ;?K=V.+$U\/AU>:7W:G-:/?>)M:O/LVGZIJ#,!EF-TX5!ZDYKT[P_I=UIJ! M[S5K^^N2.3+.Y0?12?U/Z5LQ6L4$2101K'&@PJ(,`#V%*8CVKZO!Y>L/[TY. M4OZZ'S6+QSKZ17*@\Z3_`)Z/_P!]&CSI/^>C_P#?1I-C>E)M/I7HG`.\Z3_G MH_\`WT:/.D_YZ/\`]]&F8/I1@^E`#_.D_P">C_\`?1H\Z3_GH_\`WT:9@T8/ MI0`_SI/^>C_]]&CSI/\`GH__`'T:9@^E&#Z4`/\`.D_YZ/\`]]&CSI/^>C_] M]&FX/I1M/I0`[SI/^>C_`/?1H\Z3_GH__?1INQO2E\MO2@!?.D_YZ/\`]]&C MSI/^>C_]]&CRVI?*/K0`GG2?\]'_`.^C1YTG_/1_^^C3O*]Z41B@!GG2?\]' M_P"^C0)93TD?\S4H4#M2T`-4RGK(_P#WT:8TL@8CS'_[Z-2$X!)JN3DYH`?Y MTG_/1_\`OHT>=)_ST?\`[Z-,HH`?YTG_`#T?_OHT>=)_ST?_`+Z-,HH`?YTG M_/1_^^C1YTG_`#T?_OHTRB@!_G2?\]'_`.^C1YTG_/1_^^C3**`'^=)_ST?_ M`+Z-'G2?\]'_`.^C3**`'^=)_P`]'_[Z-.2>0'EV(^M144`6Q(_]]OSIXE;^ M\?SJI$V#@]*FH&F65<^IIX8^M5%:IE-!18!IPJ)33Q0`ZBBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`X74C_`,3"Z_ZZ MM_,U5)JQJ1_XF-U_UU?^9JJ37R55^^_4^EIKW4!--)H)II-9-FB0$TTF@FFD MU#920$TPF@FFDU#9:0$TPFE)IAJ&RD@)IA-*33":S;+0A---!--)J&RT(33# M2FFFH;*0AIAI3336;+0TTTTXTPU#+0AIAIQIIJ&4A#3#3C334LI#332:4FFF MI*$--)I2:C9JD8I-,9J:6J)GJDA-CV:H7>F/)44:RW$R0V\;RRN<*B#))]A6 ML8-NR,Y3L$DGO6IH?A?5M;FC%O;216[#/VB52L>/4'O^%=MX.^'GE/%?:_@N MI#I:@Y`(_OGO].GKGI7HY``P!@#M7TF!R-S7/7T7;K_P#P<9FRB^6CKYG,>& M_"5AX?0/$//O",-<2#GZ*.P_SFMVI7J*OIJ5*%*/)!61\]5G*I+GF[L**9(2 M%XIHE..16AF2T5&)12^8M`#Z*9YBT>8M`#Z*9YBTGFB@"2BH_-'I2>;[4`2T M5#YI]*3S&H`GHJON;UI,GUH`L9'J*-P]15>B@"?>OK2>8OK4-%`%FBD'04'@ M&@".5L_*/QJ.BB@`HHHH`****`"BBB@`HHHH`****`"BBB@`J>-MR^]04^(X M;'K0`_.&J5#44G8TJ&@I%M34H-5T-2@T#)0:7-,S1F@!^:,U'FC=0!)FBF9H MS0`^BFYIE>B^#/A[]H2*_P!? MR(V`>.U!P2.V\]OI^?I7;A,%4Q4^2FO^`9WEW_`,CY?%YA4Q/N[1[?YC34;5*:8PKTS@*[BH&X M-67%0.*`$.&6H&4KUJ53@XIQ`/44$-%>BG.FT\=*;0`4444`%%%%`!1110`4 M444`%%%%`!1110`4#DBBG1C+B@">F2_M&^J^?>B@+E@-3@U5LFG!J`N60U.!JN&J16H&3`TM1@TX M&@!U%`HH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#SS53_P`3.[_Z[/\`^A&J MA-6-5/\`Q-+S_KL__H1JH37Q=5^^_4^JIKW$+FD)I"::3639HD*332:0FFDU M+920I--)I"::34-E)`332:"::34ME)`332:"::34-EI"$TTF@FFDU#920$TP MFE)IIJ&RD(3332DTTU#9:$---!II-0RD(333033&-24!-1LU(S5$[46`5GJ" M1\4UWJM+)5*)+8^22K>AZ+J&OW9@TZ'=C[\C<(@]S_DUH>$O"-]XCE$G-O8` M_-.PZ^RCN?T%>UZ+I=KHVG165BA6&/N3DL3U)/_4TC^?\`7<\G M'9E&A[D-9?D')3 M5D?-5JTZTN:;NPHHHK8R`TPBGTAH`A85"ZU:85$PH`J.M(K=CUJ9UJ!EH!HD M/-,,8-(KXX-24$;$)B;MBDV-Z5/10!7VGTI,'TJS10!6P?0TNT^E6**`*^UO M2C8WI5BB@"#8WI1Y;5/2$@=30!%Y;>U'E-ZBGF1::9?04`'E'UIR)M.>IIAD M:D5R#R6Z5*2%&3TI$&U!56>3<<# MI0)ZDC7(_A!J)IG/?%1T4`+O;U-/CF9>IR*CIP6@1:CF5N.AJ6J6RIX7(X8_ M2@";.*D5JCI.AH*3+2M4BFJR-4R&@9,*6F`T\4`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110!YOJQ_XFEY_UV?_`-"-4R:LZN?^)K>_]=G_`/0C5,FOB*K]^7J? M6TE[B]!Q--)I,TTFLFS2PXFFDTA--)J&RK"DTTFD)I":ELI("::30332:ELI M("::30332:ALI("::3033":ALI("::32DTTFI;*$)II-!--)J"D(336-!-1L MU24#-43M0S5!(]%@N*[U7DDILDE%A97>JWJ6EA"TTS]`O;W)[#WK2%-R=DM3 M.4U%79`SL[A4!9F.`!R2:]&\'_#OS%BO?$&Y>=RV>,<=BY_/Y?UZBND\&>"K M7056YN=MSJ1',F/EC]D']>OTKKJ^KR_)8PM4Q"N^W^9\[C#TJPZU`ZT`2CFHS(`<`9HB..#22(2*EH`K MN,,125+*N1D5%0`4444`%%%%`!1110`4444`%%%%`!113D0G!/2@`1-WTJ?H M*0``8%17$FU<#J:`*\S;I":?;+N;)[5#5NU&(\^M!3V"XDVK@=ZJ5+$Y?$5UYUT)(M,C^](!CS&S]T'\\GM71A\/.O-0@KMF%:O&E%SF]" MCX7\-WWB2ZVVZ^7:H<2W##Y5]AZGV_/%>R>&/#5AX<@E2Q\QWE(,DLK99L=! MP``.36K96D%C:QV]I$D,$8PJ(,`5-7VF!RRGA$I/67?_`"/E<9CZF)=MH]O\ MPHHHKTC@"BBB@`HHHH`****`"BBB@`H(HHH`:13&%2FFD4`5V6HG6K3"HF6@ M"FZX-.1L\'K4CK4++0)HM`$81CVIPB]34M%`#50#WIU'2HI)@.%Y-`"RR!![U48ECDTK$L6:R?\`B;WW_7=__0C5+-6]:/\`Q.+[_KO)_P"A&J6: M^!K/]Y+U9]E27N+T%)I":0FFDUC"7L98M5U=2+I?FAMS_P`L^.K>_H.W MUZ=V#P4\5/ECMU?8X\5BX8>'-+Y+N4_!OP^$T0O/$4;88?):[BI'NY'(^GY^ ME>G00QV\*0P1K'$@VJBC``]`*?17VV%PE+"QY::^?5GRF(Q-3$2YIOY!1117 M2G2K+K4++0`Y'##WIU5R"#Q4L;[N#UH):'TA('>D?.TXJ"@1/ MO7UIIE'85%10`\R-32Q/4TE%`!1110`4444`%31MN'/6H:DA!R3VH`E(R,&H M70CD1BI$-`%H8[4M1+4JD4`/ M1-W7@5,6")@5%OQ3&)8Y-`Q"X MTX/559".M2@@C@T#N6`]/#55!Q3U:@HM`TX&H%:I`:`)`:6F`TX&@!:***`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#R?6S_Q. M;_\`Z^)/_0C5+-6];/\`Q.;_`/Z^)/\`T(U1)K\]K/\`>2]6?:TE[D?0=FDS M30\*O\`,^@]Z]I\&>$K;P];^8^V;4''[R;'W?\`97T'\Z]3+\OG MBY=HK=GG8W&QP\?[W1">$?!UEH,"23)'@]^I_2NHHHK[6E M1A1BH4U9'RM2K.K+FF[L****T,PHHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"@BBB@!I%,(J4BFD4`0,M1LM62*C9:`*C+417'2K;+43+0`B-N' MO0R`]L&HR"#D5(K`B@EHB*,#3?K5FD(!ZB@17HJ?8OI1L7TH`@H`)Z"K&T>E M+B@"`(Q[4X1>IJ6D+`=30`@11VIU1F4=A3U.X`T`+5=N6-3MPIJO0`4444`% M%%%`!4T1ROTJ&I(3R10`RY7D-^%1J*LRKN3%5QP:"D2**D`IBU(*!ABD`R:6 ME'`H$V-D;:M5QR@(Z5(#ZTBBI5%`$9`/4`TTQ+C@8J5D( M^E-H`C$9'>G!<=Z=2$@#)H`7I5::;LA_&FRREB0.!46*"D@]S2J"3@48JS;I M@;CWH&Q\<80>]1NY8\=*=*W85'00%%%%`!1110`4444`%`..G%%%`$B2'.&J M3Z57IZ.0<$\4`3JU2JU0=>12JU!29;5J>#5=&J530,E!I:8#3A0`M%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'D>N'_B=:A_U\2? M^A&J&:N:Z?\`B=ZA_P!?$G_H1JCFOSJN_P!Y+U9]Q27N1]$+FDS29I,UC